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ABSTRACT 
 
 
 Chronic alcohol consumption causes health problems including cancers, liver 
damage, and cirrhosis.These problems are exacerbated by endotoxins from the bacterial 
population of the colon, which can enter the bloodstream when gastrointestinal tight 
junctions, protein complexes that prevent paracellular passage of molecules, are 
compromised. The mechanisms of this barrier disruption are the subject of current study. 
 
 Acetaldehyde, produced as a result of ethanol breakdown by intestinal microflora 
as well as intestinal epithelia, is a known carcinogen. It compromises the barrier function 
of intestinal epithelial cells by causing irregularities in the phosphorylation of tight 
junction proteins. It also reacts with proteins, lipids, and DNA to cause cellular 
malfunction.  
 
 This project explored the roles of PP2A (a protein phosphatase) in acetaldehyde-
mediated tight junction disruption, wound healing, and morphological differentiation. 
Intestinal epithelial cell culture in monolayers on permeable membranes were used to test 
the effects of acetaldehyde in the presence or absence of specific inhibitors on barrier 
function via transepithelial resistance and the paracellular passage of fluorescent 
molecules. Immunocytochemistry and confocal microscopy were used to track the 
localization of occludin in the cell lines tested, in cells cultured in monolayers or in a 
three-dimensional model in Matrigel. Results for acute administration of acetaldehyde 
were confirmed in mouse ileum. 
 
 Acute administration of acetaldehyde was demonstrated to have deleterious 
effects on the barrier function and wound healing of Caco-2 cells and mouse ileum, with 
varying degrees of attenuation of the effects of acetaldehyde via PP2A inhibition. 
Transepithelial resistance declined and inulin flux increased in the presence of 
acetaldehyde, as occludin was dephosphorylated and internalized by the cell in the 
presence of increased PP2A association and activity. PP2A inhibition by fostriecin, 
siRNA, or a specific peptide inhibitor not only rescued the cells from the disruption 
indicated by inulin flux, but also decreased the association of PP2A with occludin, 
resulting in preservation of threonine phosphorylation and localization of occludin at the 
tight junction. These results were confirmed by experiments with fostriecin in mouse 
ileum ex vivo. At all concentrations tested, acute exposure to acetaldehyde inhibited 
wound healing in an established in vitro model. Migration was not restored by PP2A 
inhibition, indicating that acetaldehyde's effects on wound healing were PP2A 
independent.  
 
 Chronic exposure to acetaldehyde disrupted differentiation in cells grown in 
Matrigel, as shown by changes in morphology, in a manner attenuated by fostriecin 
pretreatment. These results indicated that the known effects of acetaldehyde on cell 
differentiation may be PP2A-dependent, and that intact tight junctions with 
appropriately-phosphorylated proteins may be important for maintaining the polarity of 
differentiated Caco-2 cells. 
 vi 
 In conclusion, acetaldehyde disrupted tight junction barrier via occludin 
dephosphorylation by PP2A to cause leaky epithelia and deficient differentiation of cells. 
It slowed wound healing in a PP2A-independent manner. All of these findings contribute 
to an understanding of the mechanisms by which acetaldehyde causes health problems in 
alcoholics. 
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CHAPTER 1.    INTRODUCTION 
 
 
Ethanol Breakdown, Enzymes, and Products 
 
Ethanol consumption has been linked to a variety of health problems ranging from 
neurodegeneration to liver disease to aerodigestive and other cancers. It is estimated to be 
linked to approximately 4% of deaths and 5% of years lost to disability worldwide (IARC 
2010). Studies in Mumbai, India have found increased risk of death from liver disease, 
digestive disease, tuberculosis, oral cancer, and cardiovascular disease among drinkers 
consuming more than 33 g ethanol per day (Pednekar, Sansone, and Gupta 2011). Studies 
in Italian alcoholics have found a several-fold increased risk of death from liver cirrhosis, 
respiratory diseases, mental illness, diabetes, cardiovascular disease, cancer, and 
infectious disease (Saieva et al. 2012). Many of these health problems can be linked 
directly to the enzymatic breakdown of ethanol to form acetaldehyde, then acetate. 
Acetate is innocuous, but acetaldehyde can bind to a variety of proteins, lipids, and DNA 
in the cell, forming adducts. These adducts can interfere with normal cellular enzymatic 
reactions, slowing reaction rates and forming abnormal by-products. Acetaldehyde 
disrupts intracellular junctions in different epithelia to allow foreign substances into the 
body, causing further havoc. Ethanol breakdown in general and acetaldehyde processing 
in particular cause destructive consequences in the cells of persons engaging in acute or 
chronic high levels of alcohol consumption. 
 
 Ethanol breakdown occurs in one major pathway and several minor ones, 
which can be classified as oxidative and non-oxidative. The major pathway is conversion 
by alcohol dehydrogenase (ADH) to form acetaldehyde, with further breakdown by 
aldehyde dehydrogenase (ALDH) to form acetate. Each dehydrogenation causes 
reduction of NAD to NADH, which can cause changes in the redox status of cells with 
continued ethanol exposure (Lieber 2005) (Figure 1-1). 
 
 Other oxidative processes also exist. Cytochrome P4502E1 (CYP2E1) and 
catalase are activated by high levels of ethanol, resulting in added production of 
acetaldehyde. CYP2E1 produces hydroxyethyl radicals as well as acetaldehyde, adding to 
the oxidative stress of the cell (Comporti et al. 2010). These species add to the cellular 
stress by their production of acetaldehyde and other molecules. 
 
 Non-oxidative ethanol processing occurs through fatty-acid-processing 
enzymes and phospholipase D (PLD) . Ethanol competes with phosphatidylcholine, the 
normal substrate of PLD. Instead of phosphatidic acid, an important second messenger in 
proliferative pathways, PLD produces phosphatidylethanol by the process of 
transphosphatidylation (Rydzewska, Jurkowska, and Gabryelewicz 1996).Fatty acid 
processing enzymes such as fatty acid ethyl ester synthase form compounds such as ethyl 
stearate and ethyl palmitate (Pragst et al. 2001; Best and Laposata 2003), which stimulate 
toxic calcium release in sensitive cells (Petersen et al. 2009). These non-oxidative forms 
of ethanol processing can be lethal to cells in the pancreas and toxic in other tissues 
(Figure 1-2). 
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Figure 1-1.   Reactions Forming Acetaldehyde in Humans 
These reactions oxidize ethanol to form acetaldehyde. CH3-CH2OH is ethanol. CH3CHO 
is acetaldehyde. NADH is nicotinamide adenine dinucleotide (reduced from NAD). 
NADPH is nicotinamide adenine dinucleotide phosphate (reduced from NADP+).  
Source: Reprinted with permission. Comporti M, C Signorini, S Leoncini, C Gardi, L 
Ciccoli, A Giardini, D Vecchio, and B Arezzini. 2010. “Ethanol-induced Oxidative 
Stress: Basic Knowledge.” Genes & Nutrition 5 (2) (June): 101–109. 
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Figure 1-2.   Fatty Acid Ethyl Ester Formation and Breakdown 
A summary of reactions forming and breaking down fatty acid ethyl esters indicates a 
variety of lipid pools contributing to FAEE formation. 
Source: Reprinted with permission. Pragst F, V Auwaerter, F Sporkert, and K Spiegel. 
2001. “Analysis of Fatty Acid Ethyl Esters in Hair as Possible Markers of Chronically 
Elevated Alcohol Consumption by Headspace Solid-phase Microextraction (HS-SPME) 
and Gas Chromatography-mass Spectrometry (GC-MS).” Forensic Science International
121 (1–2) (September 15): 76–88. 
ADH, NADH, ALDH2 
When humans consume ethanol, acetaldehyde is produced by ADH in epithelial 
tissues lining the digestive tract and by bacteria and yeast occupying various parts of the 
digestive tract.  The acetaldehyde is further broken down to acetate by ALDH, an enzyme  
with low activity in intestinal bacteria, but higher activity in human epithelial cells 
(Salaspuro 1996). 
Mutations in the genes for these enzymes cause alterations in function, resulting 
in faster or slower processing of acetaldehyde by intestinal epithelial cells (Seitz and 
Becker 2007). For example, the His47Arg mutation in ADH1B results in higher risk of 
colorectal cancer (Gao et al. 2008).  This mutation attenuates the activity of ADH1B, an 
isoform of ADH found in the liver (CH Cho and Purohit 2006).  The resulting increased  
blood alcohol levels may increase the risk of colorectal cancer by unknown mechanisms, 
or may provide more alcohol for the action of bacterial ADH in the gastrointestinal tract, 
resulting in colonic acetaldehyde accumulation (Matsuo et al. 2006).   
There are three different allelic variants of the ADH1B gene responsible for most 
ethanol processing in the liver (Edenberg 2007). ADH1B*1, the reference allele common 
in Caucasians, has an Arg at positions 48 and 370 (Table 1-1). ADH1B*2 has a histidine 
at position 48. ADH1B*3 has a cysteine at position 370. Both of these mutations increase 
the turnover rate of the enzyme 70 to 80 fold because nicotinamide adenine dinucleotide 
(NADH) is released more quickly at the end of the reaction than usual (Edenberg 2007). 
Fast ADH processing can result in buildup of acetaldehyde in the system, resulting in  
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Table 1-1.   Important ADH and ALDH Polymorphisms 
 
Class and Gene Tissue Distribution 
ADH 
 
I. ADH1A  
ADH1B*1  
ADH1B*2  
ADH1B*3 
II. ADH2 
III. ADH3 
IV. ADH4 
V. ADH5 
 
ALDH 
 
I. ALDH1 
II. ALDH2*1  
ALDH2*2 
 
 
liver, lungs, kidneys 
liver, lungs, kidneys 
liver, lungs, kidneys 
liver 
all tissues 
stomach, esophagus, liver, skin, cornea 
stomach 
all tissues 
 
 
 
liver, stomach, brain (cytosol) 
liver (mitochondrion) 
liver, stomach (mitochondrion) 
 
Source: Reprinted with permission. Jelski W, and M Szmitkowski. 2008. “Alcohol 
Dehydrogenase (ADH) and Aldehyde Dehydrogenase (ALDH) in the Cancer Diseases.” 
Clinica Chimica Acta; International Journal of Clinical Chemistry 395 (1-2) 
(September): 1–5. Copyright 2008 Elsevier.  
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increased risk of acetaldehyde-specific, alcohol-related health problems (Jelski and 
Szmitkowski 2008). 
 
 ALDH mutations can also cause problems. The ALDH2 Glu487Lys mutation 
causes inactivation of ALDH, resulting in build-up of acetaldehyde in the system, facial 
flushing, and other symptoms (Yin et al. 2007). These symptoms usually protect a person 
from excessive alcohol consumption, but heterozygotes may tolerate the symptoms, 
continue to drink heavily, and increase their risk of cancer (A. Yokoyama et al. 2008).   
The ALDH2 Glu487Lys mutation is common in Asian populations (Eng, Luczak, and 
Wall 2007). 
  
 These ADH and ALDH mutations contribute to malfunctions in the colon. Studies 
from Japan and Taiwan have implicated the inactive ALDH2 and over-active ADH genes 
common in Asians in an increased risk of colorectal cancer among Asian alcoholics (T. 
Yokoyama et al. 2005; Chiang et al. 2012). In both cases, a build-up of acetaldehyde in 
the colon is part of the mechanism of increased risk. 
 
 
CYP450 2E1 (Mitochondrial Ethanol Oxidizing System) 
 
 CYP2E1 is induced by high levels of ethanol in cells, via chronic alcohol 
consumption. CYP2E1 processes alcohol to acetaldehyde, but produces superoxide 
radicals as unwanted byproducts, resulting in cellular damage (Lieber 2005)  
(Figure 1-1). When CYP2E1 is activated, it also processes exogenous chemicals in the 
body, such as carbon tetrachloride and bromobenzene, to toxic metabolites (Lieber 2005). 
This accounts for excessive liver toxicity of acetaminophen in alcoholics, as the alcohol 
and the acetaminophen act synergistically to activate CYP2E1 and harm the liver. Shortly 
after ceasing excessive alcohol consumption, alcoholics are particularly vulnerable to the 
toxic effects of CYP2E1 as the alcohol stops competing for the enzyme, and toxic 
metabolites of other environmental chemicals reach their peak (Gonzalez 2005). 
 
 CYP2E1 activation has been shown to occur in the colonic mucosa of rats and 
humans exposed to alcohol (Seitz, Maurer, and Stickel 2005), and may contribute to the 
higher risk of colon cancer in alcoholics by several mechanisms. CYP2E1 generates 
acetaldehyde, which is both mutagenic and carcinogenic (Salaspuro 2009). CYP2E1 
induction by ethanol consumption is known to increase the effects of dietary nitrosamines 
by generating DNA adducts (Gonzalez 2005). CYP2E1 may also play a role in colonic 
hyper-regeneration in rats exposed to chronic alcohol consumption, as exposure to alpha 
tocopherol, a radical scavenger, alleviates alcohol-induced colonic hyper-regeneration 
(Vincon et al. 2003). Since colonic hyper-regeneration increases the risk of colon cancer 
in humans, the activation of CYP2E1 in the presence of heavy alcohol consumption may  
be part of the pathogenesis of alcohol-related colorectal cancer. 
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Catalase 
 
Catalase is an enzyme found in peroxisomes that is capable of oxidizing alcohol to 
acetaldehyde in the presence of hydrogen peroxide (Keilin and Hartree 1945). It uses 
hydrogen peroxide to oxidize alcohol to acetaldehyde, but "leaks" free radical species in 
the process (Figure 1-1). Hydrogen peroxide generating enzymes such as xanthine 
oxidase and NADPH oxidase are necessary for its function. It seems to be an important 
source of ethanol oxidation in the kidney, heart, and brain (Orellana et al. 1998; Pastor, 
Sanchis-Segura, and Aragon 2002; Zimatkin and Buben 2007), but relatively 
insignificant in the liver (Lieber 2005).  
 
 
FAEE Formation 
 
 Fatty acid ethyl esters (FAEEs) form as a minor product during the non-oxidative 
elimination of ethanol (Figure 1-2). They accumulate in the pancreas, liver, and heart 
during acute ethanol administration (Laposata and Lange, 1986), organs damaged in 
many alcoholics. It has been shown in the pancreas that FAEEs cause lethal release of 
calcium from the endoplasmic reticulum, resulting in calcium-dependent necrosis 
(Petersen et al. 2009). The binding of FAEEs to mitochondrial membranes may 
contribute to malfunction of oxidative phosphorylation and generation of toxic fatty acids 
(Lange and Sobel 1983). 
 
 
PLD 
 
 Phospholipase D is a membrane-associated enzyme that normally cleaves 
phosphatidylcholine to release phosphatidic acid (Figure 1-3). It also produces the 
important signaling molecules diacylglycerol and lysophosphatidic acid. These molecules 
participate in signaling pathways such as regulation of kinases and matrix 
metalloproteinases (Liscovitch et al. 2000). PLD is also essential for acetylcholine 
formation in cholinergic neurons. 
 
  PLD can use short-chain alcohols as substrates to produce phosphatidylethanol 
(Liscovitch et al. 2000). Phosphatidylethanol accumulation has been shown to increase 
colonic cell proliferation and intestinal hyperplasia in rats (Pannequin et al. 2007). PLD 
has also been shown to be inhibited by ethanol in the rat pancreas (Rydzewska, 
Jurkowska, and Gabryelewicz 1996). Inhibition of PLD and competition as a substrate by 
ethanol disrupt the signaling pathways (such as stimulation of PKCs and MAPKs) 
normally modulated by the products of PLD. 
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Figure 1-3.   Effects of Ethanol on PLD Signaling 
Ethanol competes with phosphatidylcholine for the activity of phospholipase D, resulting 
in formation of non-functional phosphatidylethanol instead of phosphatidic acid (PA). 
Source: Reprinted with permission. Liscovitch, M, M Czarny, G Fiucci, and X Tang. 
2000. “Phospholipase D: Molecular and Cell Biology of a Novel Gene Family.” 
Biochemical Journal 345: 401–415. 
Acetaldehyde Pharmacology 
General Description 
Acetaldehyde, also known as ethanal or CH3CHO, is one of the "aromatics", 
volatile compounds found in low concentration in alcoholic beverages which give them a 
characteristic bouquet (Regodon Mateos, Perez-Nevado, and Ramirez Fernandez 2006). 
At low concentrations it contributes to a fruity aroma in alcoholic beverages, but in high 
concentrations it is pungent and unpleasant. It is produced by the yeast during 
fermentation from pyruvate, by the enzyme pyruvate decarboxylase (Lees and Jago 
1978). The different yeast strains used to ferment alcoholic beverages produce different 
amounts of acetaldehyde (Querol et al. 2003) under different growth conditions (Roustan 
and Sablayrolles 2002; Regodon Mateos, Perez-Nevado, and Ramirez Fernandez 2006). 
Home-brewed and distilled alcoholic beverages tend to have higher acetaldehyde levels 
than those produced in large-scale facilities (Boffetta et al. 2011), as temperature and 
brewing conditions change microflora and the resulting acetaldehyde content.
Human ingestion of ethanol results in acetaldehyde production, as ethanol is 
broken down to acetaldehyde by gastrointestinal microflora and epithelial cells. About  
2-10% of ethanol taken orally can be eliminated through the kidneys or lungs (Lieber 
2005). The rest is metabolized by the body, mostly in the liver, resulting in low blood 
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acetaldehyde levels under normal conditions (Lieber 2005) Acetaldehyde production can 
be measured in saliva following ethanol ingestion, both from acetaldehyde in the 
beverage and endogenous production by oral microflora, with heavy smokers and 
drinkers having higher levels of acetaldehyde production (Homann et al. 2000). Roughly 
40-75% of alcohol consumed in an evening of drinking is absorbed in the stomach, with 
some processed there to produce high levels of acetaldehyde in gastric juice (Lieber 
2005;  Salaspuro 2009). Microflora in the large intestine process residual alcohol and 
alcohol diffused from the bloodstream to form acetaldehyde, but lack ALDH to oxidize it 
to acetate. High levels of acetaldehyde in the saliva, gastric juice, and colonic contents 
can be traced to the action of microbes and epithelial cells, increasing the risk of digestive 
cancer (Salaspuro 2003). 
 
 
Known Hazards 
 
 The presence of acetaldehyde in the beverage, especially when consumed at 
chronically high doses, may contribute to the risk of human cancer in a variety of ways. It 
may encourage the growth of bacteria in the gastrointestinal tract which are tolerant of 
high acetaldehyde levels (Hooper, Wilson, and Crean 2009) and in turn produce more 
acetaldehyde themselves (Salaspuro 2003). It may contribute to cancer directly by 
generation of DNA adducts and DNA-protein crosslinks (Lorenti Garcia et al. 2009). 
Acetaldehyde also decreases cell differentiation with chronic exposure, decreasing cell 
adhesion to common extracellular matrix collagens and increasing proliferation (Koivisto 
and Salaspuro 1998). 
 
 
Dose Response 
 
 Dose-response information about acetaldehyde is limited by its chemical and 
physical properties. It is volatile, evaporating at 20 °C. It contains an electrophilic 
carbonyl carbon (Lorenti Garcia et al. 2009), making it highly reactive with biological 
macromolecules including DNA, proteins, and phospholipids. It is constantly formed and 
broken down in the presence of ethanol intake. Most ethanol processing takes place in the 
liver, with significant processing along the alimentary canal as well. Though 
concentrations of acetaldehyde in the blood are usually low, concentrations in the 
digestive tract are increased by the presence of bacteria with efficient ADH, but 
insufficient ALDH to break down the acetaldehyde generated (Salaspuro 1996). 
Variability in the types and processing efficiencies of the bacteria in the digestive tracts 
of individuals, as well as genetic differences in the human alcohol consumers, make 
establishing a dose of acetaldehyde per dose of alcohol in humans very difficult. The 
chemical and physical properties of acetaldehyde, as well as variations in the ability to 
process ethanol limit the dose-response information it is possible to obtain about 
acetaldehyde from alcohol consumption in free-living humans. 
 
 Some dose response information has been acquired despite the daunting 
methodological challenges. Blood concentrations of 30 μM have been noted in 
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alcoholics, with higher concentrations of 750 and 2410 μM in alcoholics actively 
drinking (Brecher, Hellman, and Basista 1997). Acetaldehyde concentrations of 100-200 
μM have been seen in the mouths of humans consuming beverages with high ethanol 
content (Homann et al. 2000). Mice with ALDH2 knockout subjected to ethanol gavage 
had blood acetaldehyde levels up to 247 μM, with wild type mice experiencing levels of 
14 μM at the same ethanol dose (Isse et al. 2005). Measurable doses of acetaldehyde tend 
to vary among subjects and species, depending on the ethanol dose, genetic background 
of the subject, enzymes induced, and presence or absence of chronic alcohol 
consumption. 
 
 
Acetaldehyde Adduct Formation: Proteins and Enzymes 
 
 
Mechanisms of Formation 
 
 Acetaldehyde is a reactive molecule, which can form protein adducts directly or 
indirectly. It may interact with lysine residues or terminal amines to produce an unstable 
Schiff base, which may be reversed or may be reduced to form a more stable adduct 
(Grazi et al. 1963; Mauch et al. 1986). More recent studies have found that alcohol-
induced aberrant lipid peroxidation in the liver produces malondialdehyde, which can 
react with acetaldehyde and protein to produce protein adducts that may induce 
inflammation and fibrosis (Tuma et al. 2001). Hydrogen peroxide and acetaldehyde react 
with an amino group on a protein to form an unstable adduct. Malondialdehyde reacts 
with another amino group to form a Schiff base. The Schiff base may be further reduced, 
allwoing more complex combinations of reactions to occur among proteins. Such 
modified proteins stimulate antibody production against the carrier proteins, causing fan 
immune response to already-stressed liver cells. The resulting proteins may form a stable 
product capable of stimulating cytokine release, inflammation, and fibrosis in the livers 
of alcohol-fed rats (Figure1-4) (Tuma et al. 2001).  
 
 
Consequences for Enzyme Activity 
 
 Several enzymes have been shown to be affected by interaction with 
acetaldehyde. For example, carbonic anhydrase II has 24 lysine residues, and has been 
shown to form Schiff-base adducts with 9-19 acetaldehyde molecules per molecule CAII. 
This interaction slows the reaction rate of the enzyme (Bootorabi et al. 2008), which 
could potentially lead to reduced gastric acid formation, reduced alkalization of 
pancreatic secretions, and other secretory difficulties involving acid-base balance. 
Acetaldehyde also affects lipoprotein lipase and hepatic lipase, altering lipid processing 
in favor of atherosclerosis by increasing triglyceride levels and serum cholesterol 
(Frohlich 1996). 
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Figure 1-4.   Formation of Protein Adducts with Acetaldehyde 
Proteins react with acetaldehyde and malondialdehyde to form inflammatory adducts as 
shown above. CH3CHO is acetaldehyde. CHOCH2CHO is malondialdehyde. Schiff bases 
(bottom of figure) can combine with other adducts to form complex protein products that 
elicit inflammatory responses in the liver. 
Source: Reprinted with permission. Tuma DJ, ML Kearley, GM Thiele, S Worrall, A 
Haver, LW Klassen, and MF Sorrell. “Elucidation of Reaction Scheme Describing 
Malondialdehyde-acetaldehyde-protein Adduct Formation.” Chemical Research in 
Toxicology 14 (7) (July): 822–832. Copyright 2001 American Chemical Society. 
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Consequences for Cell Signaling 
 
 Chronic alcohol consumption triggers upregulation of CYP2E1, a cytochrome 
P450 found in the endoplasmic reticulum (ER) (Gonzalez 2005). CYP2E1 releases free 
oxygen radicals, resulting in oxidative stress to cells. Oxidative stress leads to an 
accumulation of protein in the endoplasmic reticulum of liver cells, myocardium, and 
cells of the cerebral cortex in mice (Ji 2012), resulting in the unfolded protein response 
and ER stress. The stress response reduces protein synthesis and increases the capacity to 
fold and unload proteins, restoring homeostasis to the cell if the stress is acute. If stress is 
prolonged or chronic, as in the alcoholic, signaling changes predispose cells to apoptosis 
by activating caspases and promoting mitochondrial leakage.  
 
 Acetaldehyde plays a critical role in this response to chronic alcohol consumption. 
Acetaldehyde-protein adducts can be found in every organ tested of rats fed a chronic diet 
of 15% ethanol (Biewald, Nilius, and Langner 1998). In biopsies from patients with 
alcoholic liver disease, acetaldehyde-protein adducts were found in the rough ER and 
microsomes of hepatocytes (Paradis et al. 1996). ADH overexpression, increasing 
acetaldehyde exposure in mice fed ethanol, resulted in increased cardiac hypertrophy and 
ER stress (Li and Ren 2008). ALDH2 over-expression, which decreases acetaldehyde 
exposure, decreased ER stress and cardiac hypertrophy (Li et al. 2009). Acetaldehyde 
exposure increases ER stress and predisposes cells to apoptosis in many vital organs of 
the body.    
 
 Acetaldehyde has been shown to bind to tubulin and actin in vitro (Tuma, Jennett, 
and Sorrell 1987; Xu et al. 1989). This binding causes inhibition of tubulin assembly at 
concentrations as low as 200 μM with prolonged exposure (Tuma, Jennett, and Sorrell 
1987). This binding may contribute to cytoskeletal changes observed in cells exposed to 
acetaldehyde (Xu et al. 1989). 
 
 Acetaldehyde also affects beta-catenin and E-cadherin at the adherens junction in 
a time-dependent manner. The adherens junction, found just below the tight junction, 
functions as a point of cell-cell contact and communication. Acetaldehyde causes 
dissociation of protein tyrosine phosphatase (PTP-1B) from the adherens junction, 
resulting in phosphorylation of beta-catenin and disruption of the adherens junction 
(Atkinson and Rao 2001; Sheth et al. 2007). Tyrosine phosphorylation has been 
previously shown to cause relocalization of beta catenin to the nucleus of the cell and to 
promote its binding to TATA- binding protein (a basal transcription factor) (Piedra et al. 
2001). This binding activates the Wnt signaling pathway for proliferation (Klaus and 
Birchmeier 2008). Accumulation of beta-catenin outside the adherens junction has been 
shown to be a negative prognostic indicator in many cancers (Kren et al. 2003; Polette et 
al. 2007; Caldwell et al. 2008). Thus the acetaldehyde-induced disruption of adherens 
junctions may play an important role in cancer promotion. 
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Acetaldehyde Adduct Formation: DNA 
 
 
Mechanisms of Formation 
 
 Acetaldehyde interacts directly with DNA to produce DNA-acetaldehyde adducts 
with the potential to stop both DNA and RNA polymerases during transcription, resulting 
in mutations from the actions of DNA repair enzymes (Stein et al. 2006). These G-to-A, 
T, or C mutations can result in protein malfunction. In ALDH2 knockout mice, alcohol 
consumption with acetaldehyde accumulation results in increased formation of 
DNAadducts and mutation of immune cells (Matsuda et al. 2007; Kunugita et al. 2008).  
In human alcoholics with slow-metabolizing ALDH2, DNA-acetaldehyde adducts are 
found at much higher levels than in subjects with normal ALDH2 (Matsuda et al. 2006). 
An example of the formation of a relatively innocuous adduct which may be repaired 
properly is shown (Seitz and Stickel 2007) (Figure 1-5A). Multiple acetaldehyde 
molecules can also interact with DNA to form malondialdehyde and crotonaldehyde 
adducts, which are more complex and may result in more likely DNA damage 
(Figure 1-5B). 
   
 The acetaldehyde- DNA adduct N2-propano-deoxiguanosine has been shown to 
be able to form inter-strand crosslinks between complementary DNA molecules (Lorenti 
Garcia et al. 2009) (Figure 1-5B, C). Chromatid exchanges and DNA-protein crosslinks 
occur in cell culture in a dose-dependent manner as well (Lorenti Garcia et al. 2009). 
These results confirm increased levels of DNA damage in ALDH2-deficient alcoholics, 
whose increased levels of acetaldehyde exposure predispose them to higher risk of aero-
digestive cancers (Matsuda et al. 2006). 
 
 
Mutations and Repair 
 
Mutations due to adducts are not the only problem associated with DNA and 
acetaldehyde. Acetaldehyde is known to interact with xanthine oxidase, increasing 
production of superoxide, which cleaves folate (S Shaw et al. 1989). There is conflicting 
epidemiological data, but some studies suggest that alcoholics tend to be folate deficient 
due to their diets, and excessive alcohol consumption depletes blood folate supplies  
(Ulrich 2007; Lightfoot et al. 2008) even further.  This deficiency and depletion impedes 
DNA synthesis and repair mechanisms, increasing the risk of mutation in colorectal cells. 
Folate deficiency has been associated with improper methylation of tumor suppressor 
genes in studies of colorectal adenomas (van den Donk et al. 2007).  Other studies 
suggest that defects in methylenetetrahydrofolate reductase (decreasing the amount of 
folate available) and ADH (increasing the concentration of acetaldehyde) can combine to 
create increased cancer risk (Hirose et al. 2005). 
 
 Acetaldehyde has been shown to promote dysfunction and cancer in a variety of 
organ systems. In the respiratory system, it promotes bronchospasm and wheezing in  
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Figure 1-5.   DNA Adduct Formation in the Presence of Acetaldehyde 
A. Acetaldehyde Adduct Formation. B and C. Formation of Crosslinks.  
Source: Reprinted with permission. Seitz HK, and F Stickel.  “Molecular 
Mechanisms of Alcohol-mediated Carcinogenesis.” Nature Reviews. Cancer 7 
(8)(August): 599–612. Copyright 2007 Nature Publishing Group.
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Japanese deficient in ALDH2 (Shimoda et al. 1996). In the rat gastrointestinal system, 
high acetaldehyde levels in the stomach, small intestine, and colon from chronic  
intoxication cause hypertrophy of gastric mucosa and intestinal crypts (Pronko et al. 
2002). It contributes to neuronal death and cognitive deficits in alcoholics (Haorah et al. 
2008). Acetaldehyde promotes lipid peroxidation and oxidative stress in the liver, 
resulting in collagen production (Lieber 2005). All of these effects of acetaldehyde are 
due to its metabolism and its adduct-forming capacity with proteins, lipids, and DNA. 
 
 The gastrointestinal epithelium is exposed to acetaldehyde from mouth to rectum 
in chronic alcoholics. This exposure results in an increased risk of cancers of the mouth, 
pharynx, esophagus, stomach, colon, and rectum (Homann et al. 2000; Akhter et al. 2007; 
Seitz and Meier 2007; Salaspuro 2009).  The bacterial inhabitants of the mouth and colon 
have been shown to contribute to higher acetaldehyde levels in these areas than in the 
bloodstream of alcoholics (Salaspuro 1996; Homann et al. 2000). Higher levels of 
exposure to acetaldehyde result in detrimental effects to these parts of the body. 
 
The detrimental effects of acetaldehyde may be focused on the junctional 
complexes of gastrointestinal epithelia. These large protein complexes serve as a gate for 
paracellular passage of ions and large molecules as well as a fence to preserve apical-
basolateral polarity (Schneeberger and Lynch 2004). Acetaldehyde disrupts tight 
junctions, resulting in penetration of colonic bacterial endotoxins to the bloodstream  
(Rao, Seth, and Sheth 2004). Because the mechanism of tight junction disruption is 
poorly understood, it deserves examination in more detail. .  
 
 
Tight Junctions 
 
 
Historical Data 
 
 Tight junctions were first viewed by light microscopy in 1895, assumed to be bars 
sealing the space between epithelial cells (Bonnet 1895). With advances in electron 
microscopy, tight junctions were seen as fusions of cell membranes, binding epithelial 
cells together in a manner similar to the mortar between bricks in a brick wall by sealing 
the paracellular space between them with interwoven strands of protein (Figure 1-6) 
(Farquhar and Palade 1963; Tamura et al. 2008). The discovery that some epithelia have 
high resistance to the passage of ions, while others are "leaky", led to the discovery of 
zonula occludens 1 (ZO-1) (Stevenson et al. 1986), a structural protein, and occludin, the 
first trans-membrane protein of the tight junction to be discovered (Furuse et al. 1993). A 
focus on the tight junction as a regulator of epithelial permeability has resulted in the 
discovery of over 40 proteins interacting in a highly flexible and dynamic protein 
complex (González-Mariscal, Tapia, and Chamorro 2008). Tight junctions are far more 
than mere sealing sites between cells; they are active sites of protein-protein interaction. 
 
  Epithelial tight junctions serve to regulate the passage of ions and molecules 
between cells, and to mark the division between apical and basolateral surfaces of cells in  
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Figure 1-6.   Electron Micrograph of the Tight Junction 
 
Anastamosing strands of tight junction proteins in mouse upper small intestine are seen 
by freeze-fracture and electron microscopy. Bar is one micron.  
Source: Reprinted with permission. Tamura A, Y Kitano, M Hata, T Katsuno, K 
Moriwaki, H Sasaki, H Hayashi, et al. 2008. “Megaintestine in Claudin-15–Deficient 
Mice.” Gastroenterology 134 (2) (February): 523–534.  
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cellular differentiation (Matter et al. 2005). Passage of ions and molecules is regulated by 
to the actin cytoskeleton, allowing for changes in cytoskeletal arrangements as 
intercellular contacts change (Hartsock and Nelson 2008). Each of these protein families 
is critical to the overall function of the tight junction. 
   
 The claudin family of transmembrane proteins, which can homo- or hetero-
dimerize to form pores of varying selectivity (Colegio et al. 2002). Apical-basolateral 
separation of populations of proteins is critical to the maintenance of polarity and 
differentiation status of epithelial cells (Matter et al. 2005), and is maintained by tight 
junctions. Expression of a truncated version of occludin inhibited the ability of MDCK 
cells to maintain fluorescently-marked lipids in their normal location on the apical 
surface of the cell (Balda et al. 1996). Thus, the disruption of intestinal epithelial tight 
junctions has two undesirable consequences: unwanted substances such as endotoxins are 
allowed into the body, and depolarization of cells may be promoted (Laurent-Puig, Blons, 
and Cugnenc 1999; Rao, Seth, and Sheth 2004). 
 
 
Protein Classes  
 
 Tight junctions are complex assemblies of transmembrane proteins (occludin, 
claudins, tricellulin, junctional adhesion molecules) (Aijaz, Balda, and Matter 2006), 
scaffolding proteins (zonula occludens family, including ZO-1) (Fanning et al. 1998), and 
signaling proteins such as protein kinases (Andreeva et al. 2006) and protein 
phosphatases (Seth et al. 2007). ZO-1 and other scaffolding proteins attach this 
complexto the actin cytoskeleton, allowing for changes in cytoskeletal arrangements as 
intercellular contacts change (Hartsock and Nelson 2008). Each of these protein families 
is critical to the overall function of the tight junction (Figure 1-7). 
 
The first proteins of the tight junction to be discovered were the zonula occludens 
proteins, including ZO-1 as the first member. ZO-1 is a 225 KDa protein found in a 
variety of epithelial cells, acting as a scaffolding protein to connect transmembrane 
proteins to the actin cytoskeleton (Stevenson et al. 1986; Fanning et al. 1998). ZO-1 is 
part of the membrane-associated guanylate kinase (MAGUK) family of proteins (Fanning 
et al. 1998).  The proteins of this family contain PDZ, SH3, and GK binding domains, 
enabling them to bind and interact with a variety of other proteins. ZO-1 also has a long 
carboxy-terminal tail to enable further interactions. ZO-1 interacts with claudins and 
junctional adhesion molecules through its PDZ domains, with occludin through its GK 
binding domain, and with actin through its carboxy-terminal tail. It also binds ZONAB, a 
Y-box transcription factor released to the nucleus when the claudin-ZO-1 association is 
disrupted (Pannequin et al. 2007). ZO-1 is a vital scaffolding protein providing multiple 
binding sites for a host of tight junction proteins, as well as binding factors that 
communicate with the nucleus to drive transcription of factors increasing cell 
proliferation when cell-cell contacts through tight junctions are disrupted. 
 
 Occludin is a 65 KDa transmembrane protein with four transmembrane domains, 
two extracellular loops, and intracellular N-terminal and C-terminal tails   
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Figure 1-7.   Tight Junction Basic Structure 
 
Transmembrane proteins include occludin, claudins, and JAM-1. Scaffolding proteins 
include the ZO-1 family. These proteins provide binding sites for the transmembrane 
proteins and actin.  
Source: Reprinted with permission. Niessen CM. 2007. “Tight Junctions/Adherens 
Junctions: Basic Structure and Function.” Journal of Investigative Dermatology 127 (11) 
(November 1): 2525–2532. Copyright 2007 Nature Publishing Group. 
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(Furuse et al. 1993; Feldman, Mullin, and Ryan 2005). Multiple phosphorylation and 
binding sites on the C-terminal tail allow for interactions with ZO-1, kinases and 
phosphatases  (Chen et al. 1997). As the first transmembrane protein of the tight junction 
to be discovered, it is known to increase tight junction integrity when over-expressed and 
to play an important role in tight junction regulation. However, its functional role in the 
junction was complicated by a study in which occludin null mice were generated (Saitou 
et al. 2000). Tight junctions in these mice appeared normal, but the mice showed growth 
retardation, chronic inflammation, gastric hyperplasia, brain calcification, and 
reproductive abnormalities. Occludin does not appear to be essential for tight junction 
formation, but does seem to be important in a variety of instances for regulation of 
absorptive and secretory functions (Saitou et al. 2000). It also seems important in 
regulating epithelial differentiation and senescence in breast and colon cancers (Osanai et 
al. 2007; Luque-García et al. 2010). Because tight junctions can develop and appear 
structurally normal without occludin, but tissues lacking it show abnormalities, its role in 
tight junction regulation and maintenance is still under active investigation. 
 
 The transmembrane protein family that seems critical for tight junction pore 
formation is the claudins, a group of 24 proteins. Claudins bear no sequence homology to 
occludin, despite having similar transmembrane domains, extracellular loops, and 
regulatory and binding domains (Furuse et al. 1998). They are smaller than other tight 
junction proteins, with a molecular weight ranging from 20-27 KDa (Van Itallie and 
Anderson 2006). Claudins homo- or hetero-dimerize to form paracellular pores of 
differing charge and size, allowing for paracellular passage of small ions (Van Itallie and 
Anderson 2006). Appropriate pore formation has been shown to be critical in promoting 
the normal barrier function of the intestinal epithelium, and pathologies of claudin 
expression have been associated with gastrointestinal diseases such as colorectal cancer 
(Huo et al. 2009; Kinugasa et al. 2010).  
 
The interactions among these molecules keep the tight junctions intact (Shin, 
Fogg, and Margolis 2006). For example, occludin attaches to the N-terminal half of the 
scaffolding protein ZO-1 via its carboxy-terminal cytoplasmic domain (Furuse et al. 
1994; Fanning et al. 1998). Several different protein kinases facilitate this interaction by 
phosphorylating the C-terminal tail of occludin (Andreeva et al. 2001). 
Dephosphorylation of tight junction proteins by protein phosphatases result in their 
internalization (Nunbhakdi-Craig et al. 2002). The interactions of transmembrane  
proteins, scaffolding proteins, kinases, and phosphatases are essential to the functions of 
the tight junction. 
 
 Recently these interactions have been discovered to be even more complex than 
previously imagined. The tight junction complex appears to be highly dynamic, with 
occludin diffusing within cell membranes to areas of photobleaching in steady-state cells, 
with recovery of fluorescence on the timescale of 5-6 minutes (Shen, Weber, and Turner 
2008). Claudin-1, in contrast, does not recover fluorescence at all, suggesting 
stabilization and lack of exchangeability. ZO-1 shows an intermediate ability to move 
into a photobleached area, and that mostly from intracellular pools (Shen, Weber, and 
Turner 2008). Actin exchanges rapidly, showing increased exchange time only in 3-day-
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old as opposed to 1-day-old and 10-day-old MDCK monolayers. New and fully mature 
monolayers seem to show dynamic protein interactions with movement of different tight 
junction molecules among unique cellular pools by different mechanisms. 
 
 
Phosphorylation and Function of Occludin and Claudins 
 
 With such a dynamic system, modes of regulation are critical to understanding 
how the tight junction adjusts to different environmental stimuli. It is well known that 
tight junctions may be disrupted in vitro by a variety of stimuli including phorbol esters, 
calcium depletion, oxidative stress, and hydrogen peroxide. Studies have indicated 
changes in the phosphorylation states of tight junction proteins, and their association with 
each other, as a result of these disrupting factors. Changes in phosphorylation of tight 
junction proteins happen prior to endocytosis of tight junction proteins and often mirror 
changes in TER (Farshori and Kachar 1999). For example, claudins form charge-
selective pores allowing for paracellular permeability that results in measurable changes 
in transepithelial resistance (Van Itallie et al. 2006). Phosphorylation of claudins 1 and 4 
by PKCs has been shown to promote tight junction formation and barrier function, as 
does inhibition of PP2A (González-Mariscal, Garay, and Quirós 2010). Other tight 
junction proteins also show significant patterns of phosphorylation and 
dephosphorylation during tight junction formation and disassembly. 
 
 Serine, threonine, and tyrosine phosphorylation of occludin have been shown to 
be important for tight junction assembly; a low-molecular weight, dephoshorylated form 
of occludin does not go to the cell surface for tight junction assembly (Sakakibara et al. 
1997; Wong 1997; Farshori and Kachar 1999). Phosphorylation of occludin by PKCζ on 
threonines 403, 404, 424, and 438 of the C-terminal tail promotes tight junction assembly 
(Jain et al. 2011). PKCη has also been shown to phosphorylate threonines 403 and 404 
(Suzuki et al. 2009). Tyrosine phosphorylation via c-Src, in contrast to threonine 
phosphorylation, is present only in occludin from disrupted tight junctions, as in cells 
exposed to hydrogen peroxide (Basuroy et al. 2010). The interplay of these kinases and 
others in phosphorylating different occludin residues is important for the assembly, 
function, and disassembly of tight junctions (Andreeva et al. 2006). 
 
 Dephosphorylation by protein phosphatases has been shown to be important as 
well. For example, acetaldehyde disrupts tight junctions by activating the 
dephosphorylation of tight junction proteins by PP2A and PP1 (Seth et al. 2007). PP2A 
and PP1 bind to the cytoplasmic C-terminal tail of occludin in the presence of 
acetaldehyde, dephosphorylating it and causing its translocation from the tight junction to 
the cytoplasm (Seth et al. 2007). This process is part of the destabilization of the tight 
junction and loss of cell-cell contact, which can lead to aberrant cell growth (Polette et al. 
2007). Phosphorylation and dephosphorylation of tight junction proteins allow for 
assembly and disassembly of tight junctions. 
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Figure 1-8.   Adherens Junction Proteins 
 
Adherens junctions are important for cell-cell adhesion and signaling. They contain 
cadherins, catenins, kinases, and phosphatases. For the sake of simplicity only the 
structural proteins are shown here.  Cadherins are calcium-dependent transmembrane 
proteins bound to members of the catenin family, which serve as a scaffold to link the 
adherens junction to the cytoskeleton.  
Source: Reprinted with permission. Niessen CM. “Tight Junctions/Adherens Junctions: 
Basic Structure and Function.” Journal of Investigative Dermatology 127 (11) 
(November 1): 2525–2532. Copyright 2007 Nature Publishing Group. 
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Adherens Junctions 
 
 The adherens junction, located just below the tight junction, is critical for cell-cell 
contact and communication (Figure 1-8). It forms and maintains contact between cells so 
that the tight junction can assemble (Hartsock and Nelson 2008). Two primary proteins, 
beta catenin, a scaffolding protein, and E-cadherin, a calcium-dependent transmembrane 
protein, interact with the actin cytoskeleton and various kinases and phosphatases in a 
manner similar to occludin and ZO-1 in tight junctions (Niessen 2007). The adherens 
junction contributes stability to the tight junction, and factors disrupting one will often 
disrupt the other. 
 
 Beta catenin localization has been a subject of active investigation for many 
years, as nuclear localization of beta catenin causes activation of the usually-embryonic 
Wnt signaling pathway, causing proliferation and stem-cell-like characteristics in cancer 
cells (Fodde and Brabletz 2007). Dissociation of beta catenin from the adherens junction 
and accumulation in the cytoplasm and nucleus is associated with increased disease 
severity and metastasis in colorectal adenocarcinomas (Herter et al. 1999).  Beta catenin 
is also known to accumulate in the cytoplasm of cultured cells with reduced expression at 
the cell membrane during cell migration assays (Polette et al. 2007). Once in the nucleus, 
beta catenin binds to transcriptional activators LEF1 and TCF to activate expression of 
genes for growth factors, cell proliferation markers, and components of the Wnt signaling 
pathway, creating a feed-forward loop that encourages dedifferentiation and proliferation 
(Klaus and Birchmeier 2008). The disruption of adherens junctions by a variety of factors 
may dislodge beta catenin from its membrane-bound complex, enabling it to change the 
functions and expression levels of proteins within the cell.  
 
 
PP2A 
 
 
Structure and Function 
 
 PP2A is a ubiquitous protein serine/threonine phosphatase, acting on a variety of 
proteins in cell signaling pathways throughout the cell. In some cells, it comprises up to 
1% of the total protein (Shi 2009). It negatively regulates the G2/M transition in mitosis 
by inhibiting cyclin-dependent-kinase-activating kinase (Janssens and Goris 2001). 
Inactivation of some of its regulatory subunits, or interaction with viral oncoproteins to 
replace regulatory subunits, may result in cellular transformation by activating signaling 
pathways involving, c-Myc, Wnt, and phosphoinositide-3-kinase (Sablina et al. 2010). It 
also interacts with several proteins in the tight and adherens junctions to regulate cell-cell 
adhesion and epithelial barrier properties (Seth et al. 2007; Nita-Lazar et al. 2010).   
  
 The activity and substrate specificity of PP2A are determined by it structure and 
post-translational modifications to that structure. PP2A has three subunits: the A or 
scaffolding subunit, the B or regulatory subunit, and the C or catalytic subunit (Arroyo 
and Hahn 2005; US Cho and Xu 2007).  The A and C subunits each have two isoforms,  
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Figure 1-9.   PP2A Subunits 
 
The three subunits of PP2A are shown with their isoforms as named under different 
naming systems. The A subunit is a scaffolding subunit to which the others bind. The C is 
the catalytic subunit. Different B (B, B', B", B"') subunits determine localization and 
substrate specificity. The ST is a viral protein that can replace the B subunit to change the 
activity of PP2A.  
Source: Reprinted with permission. Arroyo JD, and WC Hahn. 2005. “Involvement of 
PP2A in Viral and Cellular Transformation.” Oncogene 24 (52): 7746–7755. Copyright 
2005 Macmillan Publishers. 
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and an AC dimer forms soon after protein translation (Janssens, Longin, and Goris 2008). 
The B subunit has several isoforms including B55 (α, β, γ, δ), B56 (α, β, γ1, γ2, γ3, δ), 
and PR72 (Janssens and Goris 2001), each of which confers different substrate specificity 
on the catalytic subunit (Figure 1-9). Post-translational modification of the conserved 
TPDYFL tail of the catalytic subunit by methylation via leucine carboxy-
methyltransferase 1 enhances binding of some B subunits, but not others(Stanevich et al. 
2011). Phosphorylation of Tyrosine 307 inactivates the enzyme (Janssens and Goris 
2001).  
 
 
Inhibition Strategies 
 
 Cells regulate the amount and activity of PP2A so tightly that some techniques 
normally used to explore protein function are difficult to achieve. Overexpression of the 
catalytic subunit of PP2A is tightly regulated at the translational level (Janssens and 
Goris 2001). Over-expressing the A subunit causes rat fibroblasts to become 
multinucleated and disrupts the cell cycle (Wera et al. 1995). Knockdown of the A 
(scaffolding) subunit or the catalytic subunit results in cell death in a variety of 
mammalian cell types (Strack, Cribbs, and Gomez 2004). Knockout of the C-α subunit is 
embryonic lethal in mice even when the C-β subtype is still present and active (Götz et al. 
1998). The inability to knock down or overexpress subunits of PP2A without serious 
impact on cell viability limits effective use of RNAi techniques normally used to examine 
protein function. 
 
 To solve the problem of tight cellular regulation in exploring PP2A function, 
pharmacological inhibitors and a recently-discovered peptide inhibitor were used. Natural 
inhibitors exist, mostly from marine dinoflagellates, cyanobacteria, marine sponges, and 
Streptomyces (Swingle, Ni, and Honkanen 2007). These compounds act by inhibiting 
catalytic activity, enabling studies otherwise made difficult by tight cellular regulation of 
PP2A expression. 
 
 Fostriecin is an antitumor phosphorus-containing compound isolated from 
medium exposed to Streptomyces pulveraceus sp. fostreus (Stampwala et al., 1983). 
Though its structure is similar to okadaic acid (another PP2A inhibitor), it is different in 
several important respects, which make it a more specific inhibitor of the serine-threonine 
kinase PP2A.  The phosphate group on fostriecin binds the manganese ions in the active 
site of PP2A directly. Fostriecin binds covalently to the cysteine-269 residue of PP2A 
(Takeuchi et al. 2009). A nearby methyl group mimics the methyl group of the substrate 
phosphothreonine. An unsaturated lactone may help to alkylate a cysteine on the active 
site loop of PP2A (Buck, et al., 2003). These specific interactions enable fostriecin to be 
a potent, specific inhibitor of PP2A (Swingle et al. 2009) (Figure 1-10). 
 
 Cell viability (as evaluated by growth inhibition using a cell count reagent) in 
L1210 cells is unaffected with treatment of up to 10 μM biotinylated Fst for 72 hours. 
This was a much greater concentration than that usually required (IC50 of 0.21 ug/ml)  
(Leopold et al. 1984) for PP2A inhibition, so short-term viability of cells treated with 
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Figure 1-10.  Structure of Fostriecin 
 
Fostriecin is a PP2A inhibitor.  
Source: Reprinted with permission. Swingle S, L Amable, BG Lawhorn, SB Buck, CP 
Burke, P Ratti, KL Fischer, DL Boger, and RE Honkanen. 2009. “Structure-Activity 
Relationship Studies of Fostriecin, Cytostatin and Key Analogues, with PP1, PP2A, PP5, 
and ({beta}12-{beta}13)-chimeras (PP1/PP2A and PP5/PP2A) Provide Further Insight 
Into Inhibitory Actions of Fostriecin Family Inhibitors.” The Journal of Pharmacology 
and Experimental Therapeutics 331 (1) (July 10): 45–53.  
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fostriecin is not an issue. 
 
 
Significance and Hypotheses 
 
 Acetaldehyde accumulates in the colonic lumen at high concentrations due to the 
activity of alcohol dehydrogenase (ADH) expressed by luminal microflora. Chronic 
ethanol consumption, with resulting production of acetaldehyde, elevates the risk for 
colon cancer. A mounting body of evidence indicates that acetaldehyde disrupts adherens 
junctions and tight junctions of the intestinal epithelium, which involves Thr-
dephosphorylation of occludin, a major tight junction protein. My studies show that 
acetaldehyde disrupts adherens junctions and tight junctions leading to barrier 
dysfunction by a mechanism that involves the activity of PP2A. Additionally, my data 
indicate that acetaldehyde inhibits migration of Caco-2 cells on cluster plates. It also has 
a negative effect on differentiation of Caco-2 cells into polarized epithelial cells when 
grown in a 3-dimensional model on Matrigel. All these studies strongly support the 
hypothesis that acetaldehyde destabilizes tight junctions and adherens junctions in the 
intestinal epithelium by a PP2A-dependent mechanism. 
 
The long-range goal of this project is to elucidate the mechanisms involved in 
ethanol-induced increase in risk for colon cancer, and if such information can be utilized 
to design therapeutics to prevent cancer promotion and tumor metastasis. As an initial 
step toward this goal I investigated the role of PP2A in acetaldehyde-mediated disruption 
of tight junctions and adherens junctions and evaluated the effect of acetaldehyde on the 
morphology of cells during three-dimensional culture in Matrigel. .   
 
 Specific Aim 1: To determine the role of PP2A and Thr-dephosphorylation of 
occludin in acetaldehyde-induced disruption of tight junctions and adherens junctions.  
Sub-aims include the following: 
 
A) Acetaldehyde disrupts tight junctions and adherens junctions by a PP2A-
dependent mechanism. 
B) Acetaldehyde induces PP2A translocation by a tyrosine kinase-dependent 
mechanism. 
C) PP2A-mediated Thr-dephosphorylation of occludin is involved in acetaldehyde-
induced disruption of tight junctions and adherens junctions. 
 
 Specific Aim 2: To determine that acetaldehyde alters migration and 
differentiation by a PP2A-dependent mechanism. To reach this goal we will determine 
that: 
 
A) Acetaldehyde promotes cell migration by a mechanism that involves PP2A and 
Thr-dephosphorylation of occludin. 
B) Acetaldehyde alters morphology of cells grown in Matrigel in a dose-dependent 
manner. 
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CHAPTER 2.    METHODS AND MATERIALS 
 
 
Cell Culture and Transfection 
 
 
Cell Types Used 
 
 Caco-2 cells were purchased from the American Type Culture Collection 
(Manassas, VA). Caco-2 cells were first isolated from a lung metastasis of a colon 
adenocarcinoma in a 72-year-old man (Fogh 1975). After the cells were grown and 
passaged in nude mice, the cells appeared to differentiate in vitro. They expressed brush 
border enzymes and microvilli at the apical surface of the cell when fully differentiated, 
at about day 20, in a similar manner to intestinal epithelia in vivo (Hidalgo, Raub, and 
Borchardt 1989). These cells are used as a model system for the intestinal epithelium in 
pharmaceutical as well as academic research applications (Hidalgo, Raub, and Borchardt 
1989; Yamashita et al. 2000; Yamashita et al. 2002) . Cell growth and differentiation may 
be carefully manipulated to mimic different stages of in vivo development of epithelia via 
changes in medium and pH (Yamashita et al. 2000; Ranaldi et al. 2003; Moyes, Morris, 
and Carr 2010). Because of the similarities between Caco-2 cell monolayers grown on 
permeable polycarbonate membranes and intestinal epithelial cells in vivo, these 
monolayers have become a prominent model for studying intestinal permeability and cell 
signaling in the simplified in vitro environment. 
 
 Caco-2 cells were grown under standard culture conditions until seeding on 
transwells for experiments. In summary, cells were grown in DMEM supplemented with 
10% fetal bovine serum. Additional supplementation with 100 IU/ml penicillin, 100 
μg/ml  streptomycin, and 50 mg/ml gentamicin was also necessary at first due to 
laboratory and building conditions outside our control. After a period of persistent 
repeated contamination incidents, 1mg/10 ml Primocin, a proprietary non-cytotoxic broad 
spectrum antimicrobial, antibiotic, and antimycoplasma solution became necessary for 
work to continue. Experimental results showed that there was no loss of protein 
expression or change in immunofluorescence staining due to this intervention. 
 
 
Cells Grown in Transwells 
   
 Cells from passages 9-40 were used. Previous data indicated that cells in this 
passage range express stable brush border enzymes, have predictable growth and 
differentiation patterns, and produce reliable trans-epithelial resistance (Briske-Anderson, 
Finley, and Newman 1997). Cells were grown on polycarbonate membranes for 7-11 
days (6.5 mm Transwells), 11-14 days (12 mm Transwells) or 17-19 days (24 mm 
Transwells) prior to incubation and experiments. These cells have been shown to 
differentiate on permeable membranes within 2-3 weeks post-seeding, so these times of 
growth post-seeding are well aligned with those in common use (Yamashita et al. 2000; 
Yamashita et al. 2002; Behrens and Kissel 2003). 
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Investigating the Role of PP2A 
 
 
Inhibition of PP2A Activity with Fostriecin 
 
 Fostriecin is a potent antitumor antibiotic first isolated from a Streptomyces 
pulveraceus culture in in 1983 (Tunac, Graham, and Dobson 1983; Stampwala et al. 
1983). It was thought to act against murine leukemias by inhibiting DNA topoisomerase 
II, but was later found to inhibit DNA, RNA, and protein production by inhibiting protein 
phosphatase 2A (Walsh, Cheng, and Honkanen 1997). It inhibits PP2A by binding 
covalently to the Cys-269 residue of the catalytic subunit (Takeuchi et al. 2009).   
 
 Fostriecin is advantageous for use because it is more selective for PP2A compared 
to PP1 than other similar compounds (Swingle, Ni, and Honkanen 2007).  For example, 
okadaic acid, the most commonly used PP2A inhibitor, inhibits PP2A at an IC50 of 0.1 to 
0.3 nanomolar. Okadaic acid inhibits PP1 at an IC50 of 15-50 nM. In contrast, fostriecin 
inhibits PP2A at 1.5 to 5.5 nM, but PP1 at 45000-58000 nM. Fostriecin is more selective 
than other available PP2A inhibitors, allowing a wider dose range for optimization and 
reduced risk of inhibiting undesired phosphatases (Table 2-1). 
 
 Fostriecin is also able to enter cells grown under typical cell culture conditions 
more readily than okadaic acid. Okadaic acid is hydrophobic, enabling it to penetrate the 
cell membrane with ease. However, that very hydrophobicity can cause it to pool on top 
of the cell culture media, isolated from the cells below. Fostriecin, a water soluble 
compound incorporated into cells through the reduced folate transporter, can be delivered 
to living cells in culture with more confidence of the actual dose accessible by the cells 
than okadaic acid and other hydrophobic inhibitors (Swingle, Ni, and Honkanen 2007). 
 
 Cells were incubated with 50 nM fostriecin in Dulbecco's Modified Eagle's 
Medium (DMEM) in apical and basal wells for 16.5 hours before each experiment. Cells 
were washed with DMEM, and fostriecin was reapplied at the beginning of each 
experiment to maintain PP2A inhibition. 
 
 
Table 2-1.   IC50 for Fostriecin and Okadaic Acid 
 
Compound PP1 PP2A PP4 PP5 PP7 
okadaic acid 15-50 0.1-0.3 0.1 3.5 >1000 
fostriecin 45,000-
58,000 
1.5-5.5 3.0 50,000-
70,000 
not 
determined 
 
Source: Data used with permission. Swingle MS, L Ni, and RE Honkanen. 2007. “Small-
molecule Inhibitors of Ser/thr Protein Phosphatases: Specificity, Use and Common Forms 
of Abuse.” Methods in Molecular Biology (Clifton, N.J.) 365: 23–38. .  
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Knockdown of PP2A-Cα by SiRNA Transfection 
 
 Small interfering RNAs (siRNAs) are used to knock down expression of a target 
gene for 3-5 days (Fewell and Schmitt 2006). These contain 19-22 base pairs to avoid the 
cellular interferon response to long dsRNA viral sequences and subsequent global 
downregulation of protein translation, which may lead to apoptosis (Paddison et al. 
2002). These constructs knock down gene expression by mimicking an intermediate in an 
endogenous gene expression regulatory pathway (Krol, Loedige, and Filipowicz 2010). 
 
 In the natural system, about 800 different small dsRNAs have been discovered in 
humans (more in plants), which fine-tune the expression of a variety of proteins by 
binding to mRNA using the miRNA induced silencing complex (miRISC). This binding 
removes the poly-adenylyl cap of the mRNA and prepares it for degradation (Krol, 
Loedige, and Filipowicz 2010). SiRNA mimics the last intermediate of this process, 
which binds the miRISC complex to downregulate mRNA translation of the protein of 
interest.  
 
 Caco-2 cells (approximately 125,000 cells/well) were seeded in six-well cluster 
plates. After 24 hours of growth, cells were incubated in serum-free, antibiotic-free 
DMEM for an hour. Cells were transfected using 100 μL Optimem, 12 μl Plus reagent, 
and 7 μl oligofectamine with 150 μl DMEM and incubated for 6-8 hours. Medium 
containing 10% serum was added, and cells were incubated at 37°C until the next day. 
Cell monolayers were trypsinized and seeded onto Transwell inserts. TER was monitored 
daily, and experiments were conducted on days 3 or 4, when TER stabilized at levels 
indicating a confluent monolayer.  
 
 
Peptide Inhibition of PP2A  
 
 TPDYFL is a universally conserved epitope at the C-terminal tail of the catalytic 
subunit of PP2A (Xing et al. 2008). Methylation of the C-terminal leucine and 
phosphorylation of tyrosine 306/307 help to determine regulatory B-subunit binding, and 
thus activity, substrate specificity, and localization of PP2A (Bryant, Westphal, and 
Wadzinski 1999; Deshmukh, Blunt, and Hofmann 2007; Longin et al. 2007). TPDYFL 
peptide seems to interfere with binding of the B subunit with the AC dimer, thus 
inhibiting activity and changing subcellular localization of PP2A (Deshmukh, Blunt, and 
Hofmann 2007).  
 
 A delivery system for the inhibitory peptide had to be optimized for the Caco-2 
cell line. The β-escin based transfection system used for cardiac myocytes (Deshmukh, 
Blunt, and Hofmann 2007) caused Caco-2 cells to detach from the underlying substrate, 
rendering them unusable for experiments. Instead we used the Chariot transfection 
reagent system (Figure 2-1), a non-cytotoxic peptide-based system which allows 
peptides or proteins to be transfected into cells without harsh reagents or electroporation 
(Morris et al. 2001; Gros et al. 2006). The peptide of choice is incubated with the Chariot  
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Figure 2-1.   TPDYFL Transfection and Chariot Peptide 
. 
The chariot peptide reversibly binds the peptide to be transfected into the cell, allowing it 
to pass through the cell membrane and to release for use on the other side.  
Source: Reprinted with permission. Gros E, S Deshayes, MC Morris, G Aldrian-Herrada, 
J Depollier, F Heitz, and G Divita. 2006. “A Non-covalent Peptide-based Strategy for 
Protein and Peptide Nucleic Acid Transduction.” Biochimica Et Biophysica Acta 1758 (3) 
(March): 384–393. Copyright 2006 Elsevier. 
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reagent for 30 minutes, forming a complex at concentrations dependent on the size of the 
well in which the cells are contained. A simple titration is used to determine the optimal 
amount of peptide and Chariot. An early trial involving Chariot and FITC-inulin 
indicated nearly universal, low-level transfection, though transfecting fully confluent 
monolayers is not recommended (Gros et al. 2006) . The Chariot reagent itself had no 
effect on barrier function or cell viability. TPDYFL inhibitory peptide and scrambled 
peptide were added at a concentration of 600 ng/transfection using the Chariot 
transfection reagent system in fully confluent monolayers on transwells two hours before 
experiments were conducted.  
 
 
Acetaldehyde Treatment 
 
 Acetaldehyde was administered to cells as previously described (Rao 1998), in a 
technique based on previous research in bovine bronchial epithelia (Sisson and Tuma 
1994). In summary, cells were pre-incubated in PBS containing 1.2 mM CaCl2 and 1 mM 
MgCl2, bovine serum albumin, and glucose for one hour. In cases such as peptide 
transfection, in which the albumin might affect results by binding the peptide, DMEM 
without antibiotics was used for pre-incubation. Transwells were placed in the center 
wells of a cluster plate. Acetaldehyde solution was placed in the outer wells. and the plate 
was quickly sealed. Control plates were sealed as well, and showed no signs of changes 
in TER or flux due to oxygen depletion. The cells were exposed to vapor-phase 
acetaldehyde at 200-600 μM concentration as described previously (Rao 1998) for time 
periods ranging from 15 minutes to 5 hours, depending on the experiment. 
 
 
Measurement of Barrier Function 
 
 
Measurement of TER 
 
 Trans-epithelial electrical resistance (TER) was measured using a Millicell-ERS 
Electrical Resistance System (Millipore, Bedford, MA). TER was demonstrated to 
correlate to the permeability and morphology of the zonula occludens, now known as the 
tight junctional protein complex, in the 1970s (Claude 1978). Total TER represents both 
the transcellular and the paracellular resistance to the passage of small ions. Under 
normal conditions in a confluent monlayer, TER depends on the packing of the cells, 
space available between them, total surface area of the monolayer, and the probability 
that pores (now known to be composed of claudin molecules) are open or closed (Claude 
1978). "Normal" values determined from previous experience in the laboratory with 
control cells from specific cell lines were used as a rough measure of monolayer integrity 
before experiments began, and were used to monitor progress as well as determine the 
effects of acetaldehyde. Calculations were completed using the following equation:   
 
Resistancemeasured=(ΔVt/ΔIt)/A-Resistancemembrane and medium 
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(Wills, Reuss, and Lewis 1996). In practice, the resistance of an empty well with medium 
was subtracted from the resistance of experimental wells with confluent monolayers. 
Percent change over the course of an experiment was used to determine efficacy of 
treatment. 
 
 Trans-epithelial resistance is not always a reliable measure of paracellular 
permeability. Because TER measures both transcellular and paracellular permeability, 
cellular adaptations can mask the effects of stress on tight junctions. In addition, high 
TER values may or may not correlate to other measures of paracellular permeability in 
Caco-2 cells (Briske-Anderson, Finley, and Newman 1997). When occludin is over-
expressed, TER increases while paracellular flux of small particles also increases, 
perhaps through the influence of pore-forming claudins (Balda et al. 1996). Therefore, 
other measures of paracellular permeability are necessary. .   
 
 
Unidirectional FITC-inulin Flux 
 
 Flux of molecules including mannitol, polyethylene glycol, and FITC-inulin from 
one side of a layer of cells to the other has been used to measure the integrity of epithelial 
monolayers and evaluate their suitability for modeling transport of pharmaceuticals for 
decades (Munck and Rasmussen 1977; Ghandehari et al. 1997). FITC-inulin has a 
molecular weight of 3000-6000, and is not actively transported into or across cells. Thus 
it is used as an indicator of tight junction integrity, as less than 0.5% of the inulin will 
move across a healthy, differentiated, confluent monolayer (Ghandehari et al. 1997). 
When the monolayer is compromised, gaps open between the cells through which large 
molecules can pass, creating a leaky barrier (Rao 1998). 
  
 Mature cell monolayers on Transwells were incubated in different experiments 
with 0.5 mg/ml FITC-inulin in the basal well. At the end of incubation with or without 
acetaldehyde and/or inhibitors, 100 μl each of medium from the apical and basal wells 
were sampled, and fluorescence was measured using a Flx-800 microplate fluorescence 
reader (BioTEK instruments, Winooski, VT). Flux into the apical well was calculated as 
the percentage of total basal well fluorescence/cm2 surface area. 
 
 
Immunofluorescence Confocal Microscopy 
 
 After incubation and exposure to acetaldehyde, cell monolayers were fixed in 4% 
paraformaldehyde in TBST (20 mM Tris, pH7.2, and 150 mM NaCl) for 15 minutes at 
room temperature or in acetone methanol (1:1) on ice for 5 minutes. Monolayers were 
permeabilized with 0.2% Triton-X 100 for 5 minutes. They were blocked in 4% milk in 
TBST( 20 mM Tris. pH 7.2, 150 mM NaCl) for one hour. They were incubated with 
primary antibodies for one hour and thirty minutes. They were washed and incubated 
with secondary antibodies for one hour. Fluorescence was visualized using a Zeiss LSM 
5 laser scanning confocal microscope, and images from 1 μm-thick x-y sections were 
collected. Images were stacked using Image J software [NIH (National Institutes of  
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Health), Bethesda, MD], and processed using Adobe Photoshop (Adobe Systems, San 
Jose, CA). 
 
 
Cell Viability Assay: Lactate Dehydrogenase Release 
 
 The Promega 96-well cytotoxicity assay was adapted to larger wells and used to 
determine the degree of cell lysis in control and experimental cell monolayers. When cell 
viability is compromised, cells release lactate dehydrogenase, which converts a 
tetrazolium salt to a red formazan product. Changes in color are measured using a 96-
well plate reader at OD450. Color change is proportional to cell lysis, making the lactate 
dehydrogenase assay a good measure of effects of cell treatments on cell viability 
(Legrand et al. 1992). 
 
 
Biochemical Analyses 
 
 
Preparation of Cytoskeletal Fractions 
 
 Cell monolayers were washed twice with PBS, then incubated with lysis buffer 
CS (Tris buffer containing 1.0% Triton-X100, 2 µg/ml leupeptin, 10 µg/ml aprotinin, 10 
µg/ml bestatin, 10 µg/ml pepstatin-A, 1 mM vanadate and 1 mM PMSF) for 15 minutes 
on ice. If fractions were to be used to measure PP2A activity, vanadate was not included 
in the lysis buffer. Extracts were centrifuged at 15,600 x g for 4 minutes at 4 °C to 
sediment the high-density actin cytoskeleton and associated proteins. The pellet was 
resuspended in lysis buffer CS. Cytoskeletal fractions were mixed with Laemmli's sample 
buffer and heated at 100 °C for 5 minutes. 
 
 
Immunoprecipitation 
 
 After acetaldehyde treatment, the cells were washed with cold 20 mM Tris-HCl, 
pH 7.4, and proteins were extracted using lysis buffer N (20 mM Tris, pH 7.4, containing 
150 mM NaCl, 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml aprotinin, 10 μg/ml 
bestatin, and 0.1 mM PMSF). Cell monolayers were extracted in 750 μl lysis buffer N, 
then two monolayers per experimental condition were pooled for immunoprecipitation. 
400 μg protein per condition was incubated with antibodies overnight. The next day, 
protein complexes were precipitated with protein A/G sepharose beads. For activity 
assays, beads were kept on ice until the assay (a few hours at most). For immunoblot 
analysis, beads were heated at 100°C for 10 minutes with Laemmli's sample buffer to 
release complexes. The sample buffer was frozen at -20°C until analysis could be done. 
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Analysis of Phosphothreonine   
 
 Cells were lysed in lysis buffer D(0.3% SDS w/v, 10 mM Tris-HCl, pH 7.4, 
containing 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml aprotinin, 10 μg/ml 
bestatin, and 0.1 mM PMSF) at 100 °C. After repeated pipetting to homogenize samples, 
samples were heated at 100 °C for 10 minutes. 400 μg protein per sample was incubated 
with anti-phosphothreonine antibodies overnight, Protein complexes were 
immunoprecipitated with protein A sepharose beads and samples processed as described 
above. 
 
 
PP2A Activity Assay 
 
 PP2A was assayed by a method adapted from (Fathi et al. 2002). Detergent-
insoluble fractions or immunocomplexes were resuspended in PPase buffer (50 mM 
HEPES, pH7.2, 60 mM NaCl, 60mM KCl, and protease inhibitors) to a volume of 20 μl. 
These samples were incubated at 30°C for 10 minutes with 5μl (1 μg/μl) of KRpTIRR 
phosphopeptide substrate. Free phosphate was assayed by adding 100 μl malachite green 
reagent to each sample in a 96-well microtiter plate and incubating at room temperature 
for 15 minutes . Absorbance was measured at 620 nm wavelength in a microplate reader 
(SpectraMax 190, Molecular Devices, Sunnydale, CA). Assay was performed in the 
presence or absence of 300 nM fostriecin and 100 nM okadaic acid. Units of PP2A 
activity represent pmol free phosphate generated under assay conditions. 
 
 
Immunoblot Analysis 
 
 Proteins were separated by SDS-polyacrylamide gel (4-12 % gradient) 
electrophoresis and transferred to nitrocellulose PVDF membranes.  Membranes were 
blotted for different proteins using specific antibodies in combination with HRP-
conjugated anti-mouse IgG or HRP-conjugated anti-rabbit IgG antibodies. The blots were 
developed using ECL chemiluminescence method (Amersham, Arlington Heights, IL).  
The bands were quantitated by densitometric analysis using Image J software (NIH). 
 
 
Animal Studies 
 
 
Animals  
 
 These studies were conducted using an IACUC approved protocol.  Adult male 
mice (C57BL/6; 12 weeks old) were used for these studies. C57BL/6 mice are the 
preferred strain for alcohol studies, as they consume alcohol willingly when not deprived 
of food or water, and they have an active complement of alcohol-processing enzymes 
(Middaugh et al. 1999; Westerlund et al. 2005). 
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Acetaldehyde Treatment of Mouse Ileum  
 
Segments of ileum were flushed and slit open longitudinally to prepare intestinal 
sheets. These tissues were incubated in DMEM at 37°C with or without 50 nM fostriecin 
for 15 minutes, followed by incubation with acetaldehyde (400 μM) for one hour as 
described previously for transwell-grown cells.  Tissues were cryofixed in OCT.  
 
 
Preparation of Detergent-insoluble Fractions from Mouse Ileum 
 
 Mouse ileal mucosal scrapings were incubated for 15 min with lysis buffer CS.  
Cell lysates were centrifuged at low speed (15,600 x g) for 4 min at 4C to sediment the 
high-density actin cytoskeleton (detergent-insoluble fraction). Supernatant was used as 
detergent-soluble fraction. The pellet was suspended in 200 µl of lysis buffer-CS and 
sonicated to homogenize the actin cytoskeleton. Protein contents in different fractions 
were measured by the BCA method (Pierce Biotechnology Inc, Rockford, IL). Triton-
insoluble and triton-soluble fractions were mixed with equal volume of Laemmli’s 
sample buffer (2x concentrated) and heated at 100°C for 5 min. 
 
 
Immunofluorescence Staining of Cryosections 
 
10 μm cryosections were stained for occludin and ZO-1 by immunofluorescence 
staining method as described above for transwell-grown cells. 
 
 
Statistical Analyses 
 
 Comparison between two groups was made by Student's t-tests for grouped data.  
Significance in all tests was set at 95% or greater confidence level. Sets with multiple 
comparisons were checked by ANOVA as applicable using AnalystSoft Inc., 
StatPlus:mac LE, version 2009. See www.analystsoft.com. 
 
 
Three-dimensional Cell Culture 
 
 
Matrigel Cell Culture 
 
 Cells were cultured in Matrigel according to a protocol assembled from several 
sources (Zhang et al. 2003; Debnath, Muthuswamy, and Brugge 2003; Xiang and 
Muthuswamy 2006). Caco-2 cells were cultured under normal cell culture conditions to 
confluency. Cells were trypsinized and pipetted gently to eliminate clumps. Matrigel was 
thawed overnight on ice in a 4 °C refrigerator before use. It was preserved in aliquots at -
20 °C to minimize freeze-thaw cycles. Each aliquot was thawed on ice before use and 
preserved on ice during use. Matrigel solidifies in minutes at room temperature. 
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 Plates were pre-coated with cold 100% matrigel before cells were deposited. 
Plates were allowed to solidify in the incubator for 20 minutes before seeding. Avolume 
of cell suspension in complete medium containing 2500- 20,000 cells with 100uL of 
Matrigel, ice cold (for a 0.7 cm2 surface), was gently dripped onto the plate, aiming for 
even coverage. Plates were placed in a 37 °C incubator immediately for gel to solidify. 
When gel was solid (time varied by lot, about 20 minutes to one hour), cells were 
overlaid with 0.2 ml DMEM with 10% FBS and primocin. New medium was added every 
other day by manual aspiration of old medium, taking care not to aspirate the gel, and 
gentle deposition of new medium. 
 
 
Treatment of Matrigel Cultures with Acetaldehyde 
 
 Acetaldehyde treatment by vapor deposition every other day was modified from 
Rao, 2008. In summary, cells were seeded in the central wells of a transwell or cluster 
plate. At day 3 (to observe effects on differentiation) or day 7 (to observe effects on 
growth), cells were treated with concentrations of acetaldehyde ranging from 0.003% to 
0.2%, pipetted as a solution in PBS-BSA-glucose in the outer wells of the plate (24 ml 
per plate). The plate was sealed and set in a dedicated 37°C incubator with 5% CO2 for 
one hour. Then cells and plate were rinsed with PBS. Cells were fed new complete 
medium and allowed to continue to grow. Cells were treated and photographed by phase 
contrast microscopy every other day. 
 
 
Fixation of Matrigel Cultures 
 
 Cells are stained in situ in the gel, so the process takes a longer time than in 
monolayers grown on membranes,  because the antibodies must diffuse through the 
extracellular matrix. Nonspecific staining may also be a problem, if washing is not done 
properly or staining is rushed. The protocols for 3D culture and processing were adapted 
and optimized from previously published protocols in kidney and breast epithelial cell 
models (Pollack, Runyan, and Mostov 1998; K Shaw, Wrobel, and Brugge 2004). During 
all aspiration, manual techniques were used to avoid aspirating the gel.  
 
 Cultures were rinsed with PBS, pH 7.4, containing 1 mM CaCl2 and 0.5 mM 
MgCl2 (PBS+) after experiments. Cells were fixed with 4% paraformaldehyde in PBS+ for 
30 minutes. Cells were washed with PBS twice, then stored in PBS plus sodium azide, 
0,05% until staining. 
 
 
Immunofluorescence for Matrigel Cultures  
 
 Sections of membrane with gel and cells attached were carefully excised from 
wells of a transwell plate and placed in a 24-well cluster plate. Cells were permeabilized 
with 0.02% Tween-20 in PBS-IF for 30 minutes. Cells were blocked with 4% milk in 
TBST for 2 hours. Then primary antibody was added at normal concentration for 
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immunofluorescence in 4% milk in TBST. Plates were sealed with tape and placed in 
cold room or 4 °C refrigerator overnight. 
 
 On the next day, cells were washed three times (10 minutes for each wash) with 
1% milk. Secondary antibodies at manufacturer-recommended concentrations were added 
and TO-PRO-3 in 4% milk. Resulting solutions were incubated 2 hours. Cells were 
washed (10 min each) with IF-PBS.  
 
 Gels were mounted on pre-labeled Superfrost microscope slides. The gel was 
gently removed from the membrane and placed in a drop of mounting fluid on the slide, 
then a few more microliters of mounting solution were placed on top, then the coverslip. 
Slides were sealed with fingernail polish, allowed to air dry, and stored at 4ºC in the dark. 
Due to challenges in sealing the slides with thick and/or uneven gels, slides were 
evaluated as soon as possible after preparation. 
 
 
Cell Migration Assays 
 
 
Background 
 
 When the intestinal epithelial barrier is breached by injury, a rapid process called 
intestinal restitution ensures that exposure of the sterile internal environment to intestinal 
contents is minimized. Then long-term healing processes can take place safely. Intestinal 
restitution is of interest because of its function in wound healing after acute trauma and 
its action in pathologies such as necrotizing enterocolitis, inflammatory bowel disease, 
and Crohn's disease. In vitro and in vivo studies have found that a sequence of steps 
occurs, including secretion of cytokines and growth factors, cell migration, and cell 
differentiation. The restoration of barrier function is followed by a longer, slower process 
of functional restoration via differentiation.  
 
 Cell migration is an essential part of the restitution process. Restoration of 
intestinal epithelial barrier function after exposure to bile salts in porcine intestine 
happens for large molecules within 30 minutes, with ion transport restored after 90 
minutes to 2 hours (Argenzio, Henrikson, and Liacos 1988), a process too fast for cell 
proliferation to play a role. Within 8 minutes, flattened cells were seen covering the 
wounded surfaces, recovering their normal columnar morphology within 2 hours. Cell 
movement is known to be dependent on actin skeletal reorganization and microtubule 
formation, but the signals to and among cells engaging in migration are still under 
investigation. A complex mixture of cytokines and growth factors is involved in the 
process, and debate continues concerning the sequence and relative importance of these 
factors, especially in the clinical setting. 
 
 The complex milieu of the large intestine also complicates matters. Cells are 
exposed to a variety of commensal and pathogenic bacteria, immune cells and their 
secretions, chemicals, and waste products as they migrate. Understanding which  
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components of this milieu accelerate and which ones inhibit the healing process is 
important for clinical applications in the treatment of necrotizing enterocolitis and 
Crohn's disease.  
 
 In order to achieve an understanding of the normal and pathological processes of 
wound healing, in vitro models of cell migration have been used to isolate and 
characterize the migrating cells. These wound healing models usually involve growing 
epithelial cells in a monolayer, then scratching or puncturing the monolayer to create a 
hole. The cells can be observed during migration, and the cellular environment can be 
altered or fully characterized much more easily than in a whole animal. 
 
 Wound healing in vitro proceeds according to certain predictable patterns, 
dependent on cell type and culture conditions. In gastric epithelia, migrating cells 
reorganize their actin cytoskeletons to form lamellipodia ("ruffles"), which can extend 
into the wounded area. Cells extend these lamellipodia or pseudopods into the wound. 
Then integrin molecules at the leading edge of the cell interact with extracellular matrix 
molecules to form focal adhesions (Decaestecker et al. 2007). Matrix metalloproteinases 
and serine proteases cleave proteins to allow the cells to continue moving forward. 
Growing actin filaments push the membrane forward, as disassembly at the rear allows 
for cell migration (Rafelski and Theriot 2004). Actin filaments are stabilized and 
contracted by myosin and other contractile proteins of the cell. When the wound is 
closed, the cells proliferate to normal cell density and reassume their normal shape and 
function.  
  
 Cells of different types migrate in different ways and at different speeds. Immune 
cells such as neutrophils may move individually in an amoeboid manner at speeds of 15-
20 microns per minute (Entschladen et al. 2005). Fibroblasts and tumor cells are 
dependent on focal adhesion and move at 0.2-1 micron/min or 0.1-0.3 micron/min, 
respectively (Entschladen et al. 2005). Colon and other epithelial cells migrate 
collectively, moving slowly while maintaining intercellular junctions (Decaestecker et al. 
2007). This collective movement contributed to the "purse-string" pattern of healing in 
circular wounds (Tétreault et al. 2008). The different movement patterns and speeds of 
different cell types contribute to complexity in migration studies. 
 
 
Acetaldehyde Treatment 
 
 Migration was assayed using common methods, adapted from Liang, et al., 2007. 
Cells were trypsinized from a confluent flask and seeded at uniform density in the center 
two wells of six-well cluster plates. Upon reaching confluence (48-72 hours), the 
monolayer was serum-starved overnight to reduce cell proliferation. Inhibitors of PP2A 
were applied one hour before treatment. Cells were treated with acetaldehyde by vapor 
deposition at varying concentrations for one or two hours, as described above. Wells 
were washed thoroughly with PBS after treatment to remove acetaldehyde, then cell 
monolayers were scratched with a razor blade or a 200 ul pipette tip. Holes were 
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photographed at three hour intervals until 60-80% closure was achieved. Phase contrast 
images were collected.  
 
 
Analysis and Quantitation 
 
 Digital images were processed in Metamorph 7 or NIS-Elements (Nikon) 
software. Measurement of 4-5 damaged areas per experimental condition in at least three 
experiments was completed using Image J software. The average rate of migration was 
calculated in Microsoft Excel by subtracting the area at the conclusion of the experiment 
(after 6 or 12 hours) from the area at the beginning of the experiment, and calculating a 
percent of area covered.  
 
 
Sources of Materials 
 
 
Reagents 
 
  Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum, and other cell 
culture reagents were purchased from Invitrogen and Fisher Scientific. FITC-inulin, 
leupeptin, aprotinin, bestatin, pepstatin A, phenylmethylsulfonyl fluoride, Triton-X-100, 
Malachite green and protein-A sepharose were purchased from Sigma. Fostriecin and 
okadaic acid were purchased from Calbiochem. PPase substrate phosphopeptide 
(KRpTIRR) was purchased from Millipore (Upstate). All other chemicals were purchased 
from Sigma or Fisher.   
 
 
Antibodies 
 
 Mouse monoclonal PP2Aα and mouse monoclonal anti-e-cadherin were 
purchased from BD Transduction (Franklin Lakes, NJ). Mouse monoclonal anti-occludin, 
rabbit polyclonal anti-ZO-1, HRP-conjugated anti-occludin, rabbit polyclonal anti-pThr, 
and anti-pSer antibodies were purchased from Zymed (San Francisco, CA). Alexa-fluor 
488-conjugated anti-mouse IgG antibody was purchased from Invitrogen. Cy3-
conjugated anti-rabbit IgG antibodies were from Sigma. Rabbit anti-caspase 3 was 
purchased from Chemicon. PP2A Aalpha antibody and goat anti-rat secondary HRP were 
purchased from Santa Cruz.   
 
 
SiRNA 
 
 Scrambled control RNA and siRNA specific to human PP2A-Cα  (sequence 
unavailable) were purchased from Dharmacon (Lafayette, CO).  
 
 39 
Peptide Inhibitor 
 
 Inhibitory peptide TPDYFL and scrambled peptide were custom-synthesized by 
Genscript (Piscataway, NJ). Control scrambled peptide TPAYFA was also synthesized by 
Genscript.  
 
 
Matrigel 
 
 Matrigel was purchased from BD Biosciences ( Bedford, MA). All other reagents 
were of analytical grade and were purchased either from Sigma or Fisher Scientific. 
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CHAPTER 3.    RESULTS 
 
 
Specific Aim 1: To Determine the Role of PP2A and Thr-dephosphorylation of 
Occludin in Acetaldehyde-induced Disruption of Tight Junctions and Adherens 
Junctions 
 
 
Acetaldehyde Disrupts Tight Junctions and Adherens by a PP2A-dependent 
Mechanism 
 
  Previous studies have shown that acetaldehyde in doses in the range used 
throughout this thesis, 600 micromolar or less, are not cytotoxic to epithelial cells for the 
time exposure (5 hours or less) used in our experiments (Grafström et al. 1994; Koivisto 
and Salaspuro 1998; Rao 1998). 
 
  Cells were exposed to acetaldehyde at concentrations of 200-600 μM for 5 hours. 
A lactate dehydrogenase assay for cytotoxicity was also performed for the same 
conditions, with comparison to a positive control of cells incubated with 0.05% Triton X-
100 for 10 minutes. 
 
  TER declined and inulin flux increased in a time-dependent manner, indicating 
that acetaldehyde disrupts tight junctions (Figure 3-1A, B). LDH assay confirmed that 
levels of cell lysis were comparable to untreated controls and several-fold lower than 
positive controls (Figure 3-2).  
 
 
Acetaldehyde Disrupts Barrier Function in Caco-2 Cell Monolayers by a 
Mechanism That Involves PP2A 
 
  Previous studies showed that acetaldehyde disrupts intestinal epithelial barrier 
function, which was associated with dephosphorylation of occludin on Thr residues (Rao 
2008; Sheth et al. 2007).  PP2A was shown to regulate the Thr-phosphorylation of 
occludin and tight junction integrity under calcium-switch conditions of tight junction 
dis-assembly and reassembly (Seth et al. 2007). To determine whether the role of PP2A 
was similar to that under calcium switch, I evaluated the effect of a PP2A inhibitor, 
fostriecin, on acetaldehyde-induced barrier dysfunction in Caco-2 cell monolayers. 
 
  Caco-2 cell monolayers were pretreated with 50 nM fostriecin for 16 hours 
followed by incubation with 200-400 μM acetaldehyde for 4 hrs. TER and inulin 
permeability were measured at the end of incubation. TER was not affected by fostriecin, 
nor did fostriecin ameliorate effects of acetaldehyde on TER (data not shown). However, 
fostriecin did prevent acetaldehyde-induced increases in inulin flux (Figure 3-3). Recent 
studies have indicated that the tight junction mechanisms responsible for the passage of 
small ions and larger molecules are different. 
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Figure 3-1.   TER and FITC-inulin Flux in Acetaldehyde-treated Cells 
TER was measured from Caco-2 cell monolayers treated with 200 μM acetaldehyde over 
a time course of four hour or from control cells. B. Inulin flux was measured the same 
sets of cells over the course of four hours. 
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Figure 3-2.   Effects of Fostriecin on Acetaldehyde-induced Tight Junction 
Disruption 
The lactate dehydrogenase assay indicates degree of cell lysis by measuring activity of 
lactate dehydrogenase released into culture medium from cells. Activity was measured in 
cells treated with acetaldehyde for five hours. Values for 0, 200, 400, and 600 μM were 
not significantly different. Positive control was cells treated with TritonX-100 for 10 
minutes. 
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Figure 3-3.   Effects of Fostriecin on Acetaldehyde-induced Tight Junction 
Disruption 
Cells with or without pre-treatment with fostriecin were sealed in cluster plates with or 
without 200 μM acetaldehyde for up to four hours.* indicates statistically significant 
difference in flux for treated cells versus control. # indicates statistically significant 
difference in flux with fostriecin pretreatment from flux in acetaldehyde-treated cells 
without fostriecin. 
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  For small ions, claudins form size-and-charge selective pores. For larger 
molecules, temporary openings form between cells, perhaps regulated by occludin, in 
ways that are not size or charge-dependent. For this reason, results for TER and FITC-
inulin flux are not always similar (Anderson and Van Itallie 2009). These results indicate 
that acetaldehyde disrupts epithelial barrier function, as measured by passage of large 
molecules, by a PP2A-dependent mechanism. 
 
 
Acetaldehyde Disrupts Tight Junctions in Caco-2 Cell Monolayers by a Mechanism 
That Involves PP2A 
 
 Acetaldehyde induces barrier dysfunction by disrupting the tight junctions 
without affecting the cell viability.  Results from TER and flux were contradictory, so we  
evaluated the effect of pharmacological PP2A inhibition on the acetaldehyde-induced 
redistribution of tight junction proteins.   
 
 Caco-2 cell monolayers were treated with fostriecin and acetaldehyde as 
described above.  Fixed cell monolayers were double labeled for occludin/ZO-1 by 
immunofluorescence; images were collected by using a confocal microscope. 
 
 Occludin and ZO-1 were co-localized at the intercellular junctions in control cell 
monolayers, indicating the presence of intact tight junctions (Figure 3-4). Acetaldehyde 
treatment induced redistribution of occludin and ZO-1 from the intercellular junctions. 
However, pretreatment of cells with fostriecin attenuated this effect of acetaldehyde. 
PP2A inhibition protected tight junction protein localization. 
 
 
Acetaldehyde Disrupts Adherens Junctions in Caco-2 Cell Monolayers by a PP2A-
dependent Mechanism 
 
 Acetaldehyde has also been shown to induce disruption of adherens junctions 
(Samak, Aggarwal, and Rao 2011). This disruption causes internalization of occludin and 
ZO-1. Adherens junction stability has been shown to influence tight junction stability 
(Nita-Lazar et al. 2010). For these reasons I examined the effects of acetaldehyde and 
PP2A inhibition on adherens junctions. 
 
 Caco-2 cell monolayers were treated with 50 nM fostriecin and 200 μM 
acetaldehyde as described above. Fixed cell monolayers were double-labeled for E- 
cadherin and β-catenin by immunofluorescence; images were collected using a confocal 
microscope. 
 
 Acetaldehyde treatment induced redistribution of E-cadherin and β-catenin from 
the intercellular junctions. E-cadherin and β-catenin wew internalized by the cell in a 
similar manner to occludin and ZO-1 at the tight junction. Fostriecin attenuated the 
disruptive effect of acetaldehyde (Figure 3-5). These results demonstrate that 
acetaldehyde disrupts adherens junctions by a PP2A-dependent mechanism. 
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Figure 3-4.   Confocal Images of Tight Junction Effects of Acetaldehyde and 
Fostriecin 
Caco-2 cells were pretreated with fostriecin for 16 hours, then treated with 200 μM 
acetaldehyde for four hours. The cells were fixed with 4% paraformaldehyde and 
immunostained for occludin and ZO-1. 
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Figure 3-5.   Effects of Acetaldehyde and Fostriecin on Adherens Junctions 
Caco-2 cells were pretreated with fostriecin for 16 hours, then treated with 200 μM 
acetaldehyde for four hours. The cells were fixed with 4% paraformaldehyde and 
immunostained for beta-catenin and e-cadherin. 
Acetaldehyde Disrupts Tight Junctions and Adherens Junctions in Mouse Ileum by 
a PP2A-dependent Mechanism 
Chronic alcohol consumption has been shown to promote colon cancer in rat and 
mouse models by exposure to acetaldehyde in the gastrointestinal tract (Pronko et al. 
2002). Since tight junction disruption may be part of the process of tumor promotion, we 
decided to examine the effects of acetaldehyde on tight junctions in mouse ileum to 
confirm our in vitro results. In vivo exposure to acetaldehyde is difficult to measure, so an 
ex vivo experiment was performed to control the acetaldehyde administration. 
We exposed mouse ileal segments to acetaldehyde at 300 μM for 60 minutes. 
Tissues were cryofixed in OCT. They were sectioned and stained by immunofluorescence 
for occludin and ZO-1 in a manner similar to that used for cell culture monolayers. 
Tight junctions were disrupted by acetaldehyde, but not by fostriecin alone 
(Figure 3-6). Treatment with fostriecin alleviated tight junction disruption, indicating 
that PP2A is involved in acetaldehyde-induced disruption of tight junctions in mouse 
tissues as well as in human cell culture.
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Figure 3-6.   Effects of Acetaldehyde and Fostriecin on Mouse Ileum 
 
Mouse ileum samples were treated with 300 μM acetaldehyde ex vivo in the presence or 
absence of 50 nM fostriecin. Cryosections were stained for occludin (green) and ZO-1 
(red). 
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Knock Down of PP2A Attenuates Acetaldehyde-induced Barrier Dysfunction and 
Tight Junction Disruption 
 
 Although fostriecin is a selective inhibitor of PP2A, it also inhibits PP4 and other 
phosphatases at high concentrations. Therefore, we evaluated the effect of knockdown of 
PP2A-Cα on acetaldehyde-induced barrier dysfunction. Caco-2 cells were transfected 
with non-specific RNA or siRNA specific for PP2A-Cα. Transfected cells grown on 
transwell inserts were exposed to acetaldehyde. Barrier function was analyzed by 
measuring TER and inulin flux and tight junction integrity assessed by confocal 
microscopy for occludin. 
 
 Immunoblot analysis showed that siRNA effectively reduced the level of PP2A-
Cα in Caco-2 cells by roughly 25%. PP1 levels varied, with some experiments showing 
no change and others showing an increase, perhaps as a cellular effort to compensate for 
the knockdown of PP2A (Figure 3-7A). Acetaldehyde-induced increase in inulin 
permeability in siRNA-transfected cell monolayers was significantly lower than that in 
control-RNA-transfected cells (Figure 3-7B). Acetaldehyde-induced redistribution of 
occludin from the junctions was attenuated in siRNA-transfected cells (Figure 3-7C). 
These results confirm that PP2A plays a crucial role in acetaldehyde-induced disruption 
of tight junctions. 
 
 
Acetaldehyde-induces PP2A Translocation by a Tyrosine Kinase-dependent 
Mechanism 
 
 Previous studies in our laboratory have shown that acetaldehyde -induced 
disruption of tight junctions and adherens junctions increases tyrosine phosphorylation of 
junctional proteins and reduced protein tyrosine phosphatase 1B(PTP-1B) activity 
(Atkinson and Rao 2001; Sheth et al. 2007). Tyrosine phosphorylation and 
carboxymethylation of PP2A on a terminal leucine are known to affect localization and 
activity of PP2A by affecting the binding of B (regulatory) subunits. The following series 
of experiments was undertaken to explore the effects of acetaldehyde on association of 
PP2A and tight junction proteins, and to explore possible mediators of increased PP2A 
association and activity. 
 
 
Acetaldehyde Increases Association of PP2A with Occludin 
 
 It has been previously shown that PP2A associates with occludin when tight 
junctions are disrupted by calcium depletion and in the presence of hydrogen peroxide  
 (Seth et al. 2007; Sheth et al. 2009). We investigated the association of PP2A with 
occludin in the presence of acetaldehyde as a possible mechanism for acetaldehyde-
mediated tight junction disruption. Cells were exposed to acetaldehyde for time periods 
ranging from 15-60 minutes, based on initial trials of up to 2 hours, indicating that the 
association peaked and faded within the first hour of treatment, before disruption was 
apparent.
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Figure 3-7.   SiRNA Knockdown of PP2A Attenuates Effects of Acetaldehyde 
 
A. Western blot and immunostaining from total cell lysate indicate levels of PP2A, PP1, 
and actin in cells treated with siRNA. B. Inulin flux in cells exposed to 400 μM or 600 
μM acetaldehyde for 5 hours. * indicates significant difference in flux (p<0.02) vs. 
control. # indicates significant effect of acetaldehyde in cells with PP2A siRNA (p<0.05) 
vs. cells with scrambled siRNA. C. Cells were exposed to acetaldehyde for five hours at 
two different acetaldehyde concentrations, then stained by immunofluorescence for 
occludin and ZO-1. 
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 Immunoprecipitation of occludin from actin-cytoskeletal-associated fractions of 
cell lysates followed short time course experiments. Half of each sample was used 
immediately for PP2A activity assay, while the other half was used for immunoblot 
analysis to determine occludin-PP2A association. PP2A activity was measured using the 
substrate KRpTIRR and malachite green color change in the presence of free phosphate. 
PP2A activity associated with occludin increased over time of acetaldehyde treatment 
(Figure 3-8A). PP2A physical association with occludin peaked between 30 and 60 
minutes after initiation of acetaldehyde exposure, corresponding roughly to activity data 
(Figure 3-8B, C). These results indicate that PP2A association with occludin rises with 
activity upon exposure of cultured human epithelial cells to acetaldehyde. 
 
 
PP2A Translocation Inhibitor Attenuates Acetaldehyde-induced Barrier 
Dysfunction and Tight Junction Disruption 
 
 Previous PP2A inhibition had shown attenuation of acetaldehyde-induced 
disruption of barrier function, but siRNA knockdown of PP2A was unimpressive and the 
pharmacological inhibitor could also inhibit PP4 and PP6. Another method of inhibition 
was needed. TPDYFL is an inhibitory peptide previously used by another researcher in 
our department in a study of cardiac myocytes (Deshmukh, Blunt, and Hofmann 2007). 
Cells were treated with TPDYFL using the Chariot system to carry the peptide into the 
cell. After two hours of pre-treatment, cells were treated with 200 μM acetaldehyde for 
four hours. TER and flux were measured. Cells were fixed with paraformaldehyde and 
stained for occludin and ZO-1. FITC-inulin flux data indicate that pre-treatment with 
TPDYFL to inhibit PP2A alleviated the usual acetaldehyde-induced increase in flux 
(Figure 3-9A). As with fostriecin treatment, short-term PP2A inhibition did not affect 
TER (data not shown). Occludin-PP2A co-immunoprecipitation indicates that the usual 
increase in PP2A association with acetaldehyde is attenuated by TPDYFL (Figure 3-9B). 
Confocal images confirm that tight junctions appear to be more stable in the presence of 
acetaldehyde in cells subject to TPDYFL PP2A inhibition (Figure 3-9C). 
 
 
Tyrosine Kinase Activity Mediates Acetaldehyde-induced PP2A Translocation  
 
 Previous studies have shown that tyrosine phosphorylation on Y309 is important 
for activation and localization of PP2A (Deshmukh, Blunt, and Hofmann 2007). Because 
tyrosine phosphorylation has been previously shown to increase in tight junction proteins 
in the presence of acetaldehyde, resulting in tight junction disruption, we examined the 
effect of genistein, a known tyrosine kinase inhibitor, on the association between PP2A 
and occludin.Cells were exposed to 200 μM acetaldehyde in the presence or absence of 
100 μM genistein for one hour. In the presence of acetaldehyde, PP2A association with 
occludin is increased within the first hour (Figure 3-10). With genistein treatment, the 
association of PP2A and occludin did not increase with acetaldehyde treatment. A 
representative blot is not available because these values were normalized to expression of 
actin. 
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Figure 3-8.   Effects of Acetaldehyde on PP2A Activity and Association with 
Occludin 
A. In vitro PP2A activity assay from occludin immunoprecipitate in the presence of 200 
μM acetaldehyde for exposure times up to one hour with or without fostriecin. * 
represents significant change in PP2A activity (p<0.02) compared to controls. B. Co-
immunoprecipitation of occludin and PP2A from same cell lysates as the activity assay 
confirms increased association as well as activity. C. Densitometric analysis of several 
co-immunoprecipitations confirms representative blot. * indicates significant difference 
in PP2A-occludin association compared to controls (p<0.05). 
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Figure 3-9.   Effects of Peptide Inhibition on Acetaldehyde-induced Tight Junction 
Disruption 
 
A. FITC-inulin flux with TPDYFL pretreatment in the presence or absence of 200 μM 
acetaldehyde for four hours. * indicates significant difference in inulin flux compared to 
control. # indicates significant attenuation of acetaldehyde effect. B. Cells treated with 
acetaldehyde were fixed in 4% paraformaldehyde and immunostained for occludin and 
ZO-1. 
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Figure 3-10.  Genistein Effect on PP2A Association with Occludin 
 
Densitometric analysis of three experiments with co-immunoprecipitation of PP2A and 
occludin from cells pre-treated with 100 μM genistein, and treated with 200 μM 
acetaldehyde. * indicates significant increase of association of PP2A with occludin in the 
presence of acetaldehyde. # indicates significant decrease of association in the presence 
of genistein compared to acetaldehyde-treated controls. 
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Acetaldehyde Dephosphorylates Occludin on Threonine Residues by a PP2A-
dependent Mechanism 
 
 Threonine dephosphorylation of occludin, and involvement of PP2A, have been 
demonstrated in previous studies in our laboratory examining the disassembly and 
reassembly of tight junctions in the presence of altered calcium concentrations in cell 
media (Seth et al. 2007). In this series of experiments, we explored the threonine 
phosphorylation status of occludin in the presence of acetaldehyde treatment. 
Cells were exposed to 200 μM acetaldehyde for time periods ranging from 15 to 60 
minutes, after initial studies indicating that threonine dephosphorylation occurred within 
the first hour. Occludin was dephosphorylated on threonine residues, with maximum 
dephosphorylation occurring between thirty and sixty minutes after initiating 
acetaldehyde treatment (Figure 3-11).  
 
 
PP2A Translocation Inhibitor Blocks Acetaldehyde-induced Threonine 
Dephosphorylation 
 
 Previous studies have shown that PP2A dephosphorylates occludin on threonine 
residues as described above. We used TPDYFL, a specific peptide inhibitor, to examine 
the effects of inhibiting PP2A translocation on threonine dephosphorylation. After two 
hours of pretreatment with 500 ng peptide, the confluent monolayers were exposed to 200 
μM acetaldehyde for time periods up to one hour. Results shown are for the 30-minute 
time point, correlating with earlier data for fostriecin protection. Inhibition of PP2A using 
a specific peptide inhibitor protects the phosphorylation of threonine residues of occludin 
in the presence of acetaldehyde (Figure 3-12). 
 
 
Tyrosine Kinase Activity Mediates Acetaldehyde-induced Occludin 
Dephosphorylation 
 
 Previous studies of PP2A regulation have indicated that phosphorylation of Y307 
is part of the activation of PP2A (Gentry et al. 2005). Since tyrosine phosphorylation of 
tight junction and adherens junction proteins has been shown to be altered in the presence 
of acetaldehyde (Atkinson and Rao 2001), we examined the effects of genistein (a known 
tyrosine kinase inhibitor) on PP2A dephosphorylation of threonine in the presence of 
acetaldehyde. Cells were pre-treated with 100μM genistein for one hour.  They were then 
exposed to 200 μM acetaldehyde for one hour. Cells were lysed and the actin 
cytoskeleton-associated fraction was subjected to immunoprecipitation for threonine-
phosphorylated proteins. Immunoblot analysis for occludin and claudins followed. 
 
 In the presence of acetaldehyde, occludin threonine phosphorylation declines 
(Figure 3-13A, B), but genistein protects occludin from dephosphorylation. Claudin-5, 
another tight junction transmembrane protein, is also threonine-dephosphorylated in a 
manner independent of tyrosine kinase inhibition (Figure 3-13A).
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Figure 3-11.  Effects of Acetaldehyde and Fostriecin on Threonine Phosphorylation 
of Occludin 
 
A. Cells were pre-treated with fostriecin for 16 hours, then sealed into cluster plates in 
the presence or absence of acetaldehyde for up to one hour. Immunoprecipitates of 
threonine-phosphorylated proteins from actin-cytoskeleton-associated cell lysates were 
immunoblotted for occludin. B. Densitometric analysis of three experiments is shown at 
the 30 minute time point. * indicates significant difference in threonine phosphorylation 
compared to control. # indicates difference in threonine phosphorylation with fostriecin 
pretreatment. 
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Figure 3-12.  PP2A Inhibition with TPDYFL Restores Threonine Phosphorylation 
of Occludin 
 
Cells were pretreated with 500 ng TPDYFL for two hours before 30 miniutes of 
treatment with acetaldehyde. Threonine-phosphorylated proteins were 
immunoprecipitated from actin-cytoskeleton-associated cell lysates and immunoblotted 
for occludin. * indicates significant difference (p<0.02) in threonine phosphorylation 
with acetaldehyde treatment. # indicates significant difference (p<0.02) with pretreatment 
with TPDYFL compared to acetaldehyde-treated cells without pretreatment. 
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Figure 3-13.  Effects of Tyrosine Kinase Inhibition with Genistein on Acetaldehyde 
induced Threonine Dephosphorylation of Occludin 
 
A.  Cells pre-treated with 100 μM genistein or control cells were exposed to 200 μM 
acetaldehyde for one hour. Immunoprecipitation of threonine-phosphorylated proteins 
and immunoblot for occludin and claudin-5 followed. Loading controls ("input") from 
total cell lysate for occludin and actin are included. B. Densitometry for threonine 
phosphorylation of occludin in the presence or absence of 200 μM acetaldehyde and 100 
μM genistein. * indicates significant difference (p<0.05) in threonine dephosphorylation 
of occludin compared to control. # indicates significant difference (p<0.05) from 
acetaldehyde-treated cells. 
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Acetaldehyde-induced Activity of PP2A Does Not Depend on Changes in PP2A 
Methylation Status  
 
 Studies of the regulation of PP2A activity have shown that terminal 
carboxymethylation of  L309 is important for substrate specificity and localization of 
PP2A (Bryant, Westphal, and Wadzinski 1999; Xing et al. 2008). However, other studies 
have shown that carboxymethylation is not necessary for B-subunit binding and PP2A 
activity in all cases (Ikehara et al. 2007). Therefore we examined whether acetaldehyde 
induced an increase in the methylation of PP2A as an explanation of its increased binding 
and activity. Cells were treated with 200μM acetaldehyde for one hour. Total cell lysate 
was immunoblotted for methylated PP2A C-α. Acetaldehyde treatment did not change 
the amount of methylated PP2A as demonstrated by Western blot (Figure 3-14) at the 
thirty minute or one hour time points, when PP2A was activated and translocated in 
previous experiments. After repeatedly generating this result, we believe that methylation 
of PP2A is not influenced by acetaldehyde.  
 
 
Specific Aim 2: To Determine That Acetaldehyde Alters Migration and 
Differentiation by a PP2A-dependent Mechanism 
 
 
Acetaldehyde Promotes Cell Migration by a Mechanism That Involves PP2A and 
Thr-dephosphorylation of Occludin 
 
 Two types of cell migration assays were attempted: scratch wounding and 
transmigration. Transmigration did not work (data not shown) because the Caco-2 cells 
did not pass through the 8-micron pores of a permeable filter upon acetaldehyde 
stimulation. Caco-2 cells are used as a monolayer through which immune cells pass in 
models of gastrointestinal immune function (Rescigno et al. 2001). They are also used as 
a model for the invasion of Candida albicans by intra- and intercellular migration (Weide 
and Ernst 1999). Other types of cells can migrate through membranes with a confluent 
monolayer of Caco-2 cells, but the Caco-2 cells themselves do not move. The 
transmigration model was attempted, but Caco-2 cells do not migrate across membranes 
upon acetaldehyde stimulation. 
 
 Several types of scratch wounding were attempted. First, using a razor blade to 
scratch away a large portion of the monolayer was used for experiments examining the 
effect of hydrogen peroxide on FAK and Src signaling. In these experiments, I noted 
difficulty with reproducibility because the blade often gouges the underlying plastic, 
leaving small valleys the cells cannot cross in the migration process. I optimized the 
technique using collagen coating of the plates prior to seeding, but the reproducibility 
issues remained. I then attempted other scratch techniques from the literature including 
using a fine metal-toothed comb (stippling, scraping, and stippling with rotation), 
stippling or scraping with a gel-loading pipette tip, placing a tiny drop of acid on the 
monolayer, and suction using a Pasteur pipette. Of all these techniques, the one yielding 
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Figure 3-14.  Methylation Status of PP2A in the Presence of Acetaldehyde 
 
Cells were exposed to 200 μM acetaldehyde for 30 minutes or one hour. Total cell lysate 
was immunoblotted for methylated PP2A C-α, with β-actin loading control. 
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the most consistent results was stippling small holes with a gel-loading pipette tip. 
Scraping a linear hole and watching the cells migrate to close it over time, as is done in 
many other wound-healing models (Bindschadler and McGrath 2007), does not work 
with Caco-2 cells due to their strong intercellular connections. A large or ragged hole, or 
one ripped quickly and with force, increases the probability that the monolayer will 
detach from the substratum, rendering it useless for cell migration purposes. Several 
experiments using small round holes were conducted.  
 
 
Acetaldehyde Inhibits Cell Migration in Caco-2 Cells at Low Concentrations 
 
 Acetaldehyde is known to disrupt tight junctions, and disrupted cell-cell junctions 
have been previously demonstrated to promote cell migration. These experiments were 
completed in an attempt to show that acetaldehyde promoted cell migration. Cells were 
seeded in six-well cluster plates. After five hours of acetaldehyde treatment, confluent 
cell monolayers were scratched with a pipette tip to form small holes (Figure 3-15A). 
After six to twelve hours, scratches were examined for closure. Photomicrographs of 
phase contrast images were saved as TIFs or JPEGs using Metamorph 8 or NIkon NIS-
Elements software. Images were compared from time zero to ending time points. Percent 
closure was calculated by drawing outlines of the holes using Image J and calculating 
changes in enclosed area with Microsoft Excel.  
 
 At concentrations several-fold lower than those used for typical Transwell 
experiments, acetaldehyde did not promote cell migration. At the six hour time point 
displayed, the lowest concentration of acetaldehyde inhibited migration (Figure 3-15B). 
At normal concentrations used in Transwell experiments, cells detached (data not 
shown). These results indicated that acetaldehyde may delay wound healing in 
gastrointestinal epithelia. 
 
 
Inhibition of Migration by Acetaldehyde Exposure is Not PP2A-dependent 
 
 Acetaldehyde exposure at high concentration has been previously shown in my 
experiments to cause disruption of tight and adherens junctions in confluent cell 
monolayers. Promotion of cell migration in the presence of this disruption was expected 
based on previous studies in other contexts. Cells were exposed to acetaldehyde 
concentrations including those typically used for acute exposure experiments in the 
laboratory (100-300μM). Initial experiments in which these higher concentrations of 
acetaldehyde tended to cause cell detachment led to experiments with a range of much 
lower concentrations, as displayed below. After five hours of exposure to acetaldehyde in 
sealed cluster plates, cell monolayers were scratched with a pipette tip and migration was 
observed over the course of the next twelve hours.  
 
 All concentrations of acetaldehyde inhibited migration in a dose-dependent 
manner, with inhibition not significantly rescued by fostriecin at any concentration 
(Figure 3-16). Cells exposed to concentrations of acetaldehyde above 100 μM tended to 
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Figure 3-15.  Cell Migration Dose Response in the Presence of Acetaldehyde 
 
A. Representative scratches and measurement technique are shown. Image J was used to 
calculate each encircled area, with changes over time graphed in Microsoft Excel as 
percent closure. B. Data from several dose-response experiments with treatment of cells 
with acetaldehyde for five hours, followed by six hours of observation, are shown. * is 
significantly different from control (p<0.2).
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Figure 3-16.  Effects of Fostriecin at Range of Concentrations of Acetaldehyde 
 
Cells in monolayers grown on cluster plates were treated with a range of concentrations 
of acetaldehyde, with or without pretreatment with 50 nM fostriecin. * indicates wound 
closure significantly different from control (p<0.02) after five hours acetaldehyde 
treatment, wounding, and twelve hours wound closure. 
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detach. Inhibition of wound healing by acetaldehyde at any concentration is probably not 
PP2A-dependent.  
 
 
Acetaldehyde Affects Growth and Differentiation of Caco-2 Cells by a PP2A-
dependent Mechanism 
 
 As discussed in the introductory chapter, alcohol consumption increases the risk 
for colon cancer (Salaspuro 2009). Acetaldehyde formation seems to play a crucial role in 
this effect of ethanol. Our studies described above show that acetaldehyde disrupts both 
tight junctions and adherens junctions. Since the dissociation of tight junctions and 
adherens junctions may result in morphological changes in cells, we investigated whether 
acetaldehyde affected the epithelial differentiation of Caco-2 cells when grown in a 3-
dimensional model. Caco-2 cells were grown on Matrigel as described in the Methods 
chapter. After 3 days of growth, cells were exposed to acetaldehyde (200 μM) for one 
hour every day. The control group was treated similarly without acetaldehyde. On day 
nine of growth, phase contrast images were collected. Cells were fixed with 4% 
paraformaldehyde and immunostained for occludin and ZO-1. 
 
 Caco-2 cells on Matrigel grew to form a three-dimensional cyst-like structure, 
consisting of a monolayer of polarized epithelial cells enclosing a central cavity. Phase 
contrast images show that acetaldehyde at concentrations normally used for acute 
exposure experiments attenuated the differentiation into cysts; rather, the cells appeared 
dispersed without polarization. This was confirmed when the distribution of occludin and 
ZO-1 was visualized by confocal microscopy. In control cells, occludin and ZO-1 were 
co-localized at the apical end (facing the cavity) of the epithelial cells (Figure 3-17), 
while such organization of occludin and ZO-1 was absent in acetaldehyde-treated cells. 
These results indicate that acetaldehyde attenuates epithelial differentiation of Caco-2 
cells. 
 
 
Acetaldehyde-induced Differentiation Problems Are PP2A-dependent 
 
  Our studies described above show that acetaldehyde disrupts both tight junctions 
and adherens junctions. Since the dissociation of junctions and adherens junctions may 
result in morphological changes in cells, we investigated whether fostriecin influenced 
the effect of acetaldehyde on morphological changes in differentiation, and whether a 
lower dose of acetaldehyde would have an effect. Cells were grown in Matrigel following 
previously-described protocols. Treatment with acetaldehyde started at day three, and 
continued every other day until day twelve. Cells were pre-treated for one hour with 50 
nM fostriecin. 
 
 Fostriecin attenuated the acetaldehyde-induced prevention of epithelial 
differentiation. Fostriecin-treated cells with or without acetaldehyde showed organization 
of cells into polarized epithelium in a cyst-like structure, similar to control cells
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Figure 3-17.  Effects of Acetaldehyde at High Concentration on Growth in Matrigel 
 
Cells exposed to 200 μM acetaldehyde for one hour, daily, are compared to control cells. 
Phase contrast of cells at day 12 post-seeding is displayed with immunostaining for 
occludin and ZO-1. 
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(Figure 3-18A). Localization of occludin and ZO-1 were also affected (Figure 3-18B). 
This study suggests that PP2A activity may play a role in acetaldehyde-induced 
attenuation of epithelial differentiation 
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Figure 3-18.  Cells Exposed to Reduced Acetaldehyde Concentrations in the 
Presence or Absence of Fostriecin 
 
Cells were exposed to 25 μM acetaldehyde with or without pretreatment for one hour 
with 50 nM fostriecin. A. Phase contrast images are shown at day 12. B. Cells were fixed 
and stained for occludin and ZO-1. 
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CHAPTER 4.    DISCUSSION 
 
 
Acetaldehyde Disrupts Apical Junctional Complexes and Barrier Function in 
Intestinal Epithelium by a PP2A-dependent Mechanism 
  
 Acetaldehyde, the most toxic product of ethanol metabolism, is involved in tissue 
injury in several organ systems. Although acetaldehyde is well known to disrupt 
intestinal epithelial tight junctions and increase paracellular permeability (Rao 1998; 
Atkinson and Rao 2001; Rao 2008), the mechanism involved in this process of tight 
junction disruption is poorly understood. Understanding the mechanism is important 
because junctional-complex disruption contributes to liver disease in alcoholics, with 
remediation by glutamine administration (Rao, Seth, and Sheth 2004), and is suspected to 
contribute to the increased risk of aerodigestive cancers in alcoholics (Salaspuro 2009).   
 
 Our present studies show that concentrations of acetaldehyde used in our 
laboratory disrupt tight junctions, but do not cause cell lysis in the time course used. LDH 
assay indicated no more lactate dehydrogenase release in cells treated for five hours at 
three of our highest concentrations than in controls. However, tight junctions and 
adherens junctions were disrupted as indicated by FITC-inulin flux, TER, and the 
redistribution of tight and adherens junction molecules as seen by immunostaining and 
confocal microscopy. These results correlate with those obtained in earlier published 
work from our laboratory and others (Rao 2008; Fisher, Swaan, and Eddington 2010) 
  
 Inhibiting the serine/threonine dephosphorylation of tight and adherens junction 
proteins may help to protect the tight junctions. PP2A is known to interact with tight and 
adherens junction proteins to dephosphorylate them (Seth et al. 2007; Nita-Lazar et al. 
2010), so inhibition of PP2A was investigated in the context of acetaldehyde-induced 
junctional complex disruption by three methods: pharmacological inhibition with 
fostriecin, peptide inhibition with TPDYFL, and siRNA knockdown.  
 
 Fostriecin is a selective inhibitor of PP2A activity (Swingle, Ni, and Honkanen 
2007).   Our present study shows that pretreatment of Caco-2 cell monolayers with 
fostriecin significantly lessens acetaldehyde-induced barrier dysfunction, as indicated by 
TER and FITC-inulin flux.  Attenuation of acetaldehyde-induced redistribution of 
occludin, ZO-1, E-cadherin and β-catenin by fostriecin indicates that inhibiting PP2A 
keeps apical junctional complexes intact in the presence of acetaldehyde.  
The adherens junction is not a physical barrier to macromolecular transport across the 
epithelium. However, it is known to indirectly regulate the integrity of tight junctions, 
and therefore influence the barrier function. Previous studies indicated that redistribution 
of e-cadherin and β-catenin plays a crucial role in acetaldehyde-induced barrier 
dysfunction in Caco-2 cell monolayers (Sheth et al. 2007). The current study indicates 
that the redistribution of e-cadherin and beta-catenin may be PP2A-dependent. 
 
 Because fostriecin inhibits PP4 and PP6 as well as PP2A, a non-cytotoxic, 
specific inhibitor of PP2A was sought. The TPDYFL peptide, from a universally 
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conserved motif at the c-terminal end of the catalytic subunit, met this need. After 
determination and optimization of an appropriate delivery method, experiments to clarify 
the role of PP2A and confirm the fostriecin data commenced. These studies were 
conducted to seek insight into the mechanism of acetaldehyde-induced PP2A 
translocation. Sub-cellular translocation of PP2A is known to be regulated by post-
translational modification at the C-terminal sequence TPDYFL (Ogris, Gibson, and 
Pallas 1997; Bryant, Westphal, and Wadzinski 1999; Gentry et al. 2005).  Previous 
studies demonstrated that a synthetic peptide with this sequence altered PP2A 
translocation and activity in cardiac myocytes (Deshmukh, Blunt, and Hofmann 2007). 
Our study demonstrated that TPDYFL prevented acetaldehyde-induced tight junction 
disruption and barrier dysfunction, as indicated by attenuation of FITC-inulin flux in the 
presence of acetaldehyde and confirmed by immunofluorescence microscopy. These 
results confirmed co-immunoprecipitation and PP2A activity data from the fostriecin 
studies, indicating that PP2A translocation is an essential step in the mechanism of 
acetaldehyde-induced tight junction disruption. Details of this mechanism remain to be 
investigated. 
 
 Previous studies showed that overexpression of PP2A disrupted tight junction 
integrity in MDCK cells (Nunbhakdi-Craig et al. 2003).  Disruption of tight junctions by 
calcium depletion involved increased association of PP2A with the tight junction protein 
complex, and calcium-mediated reassembly of tight junctions was associated with 
dissociation of PP2A from tight junctions in Caco-2 cell monolayers (Seth et al. 2007).  
Inhibition of PP2A activity or knockdown of PP2A-Cα resulted in acceleration of 
calcium-induced tight junction assembly (Seth et al. 2007).  Furthermore, PP2A activity 
was found to be involved in hydrogen peroxide-mediated disruption of tight junctions in 
Caco-2 cell monolayers (Sheth et al. 2009). These previous studies led us to believe that 
PP2A involvement in the acetaldehyde-induced disruption of tight junctions could be 
productively investigated by PP2A knockdown with siRNA.  
 
 PP2A knockdown, however, is not without its disadvantages. Appropriate 
expression of the A (scaffolding) subunit is critical for survival, and knocking it down 
significantly, even in an inducible manner, causes cell death by apoptosis and necrosis 
(Strack, Cribbs, and Gomez 2004). Suppression of the PP2A C? subunit by more than 
50% causes apoptosis and poor proliferation (Sablina et al. 2010). Suppression of the 
B56? subunit recapitulates some, but not all, of the transforming features of the SV-40 
small T antigen. PP2A suppression by siRNA must be used with caution, especially when 
cell viability is important.  
 
 The role of PP2A in acetaldehyde-induced tight junction regulation was 
confirmed by knockdown of PP2A using PP2A-Cα-specific siRNA. Though PP2A was 
only knocked down by 20-25% in our experiments, knockdown of PP2A dampened the 
effects of acetaldehyde on inulin permeability. It attenuated redistribution of occludin and 
ZO-1 from the intercellular junctions. Our present study demonstrates by multiple 
methods that PP2A is involved in acetaldehyde-induced disruption of tight junctions. 
However, we do not know important details about PP2A in the context of the tight 
junction. We do not know which B-regulatory subunits are involved in PP2A 
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translocation to the tight junctions. Initial attempts to determine which B-regulatory 
subunits of PP2A were involved in acetaldehyde-mediated tight junction disruption were 
unsuccessful due to transfection problems with shRNA constructs. Trying again with 
different constructs or a more tractable cell line may result in more detailed knowledge 
about the specific PP2A B-regulatory subunits involved.  
 
 To establish the physiological relevance of the role of PP2A in tight junction 
regulation in the presence of acetaldehyde, we determined the effect of acetaldehyde and 
fostriecin on tight junction integrity in mouse intestine. Acetaldehyde induced 
redistribution of occludin and ZO-1 from the intercellular junctions of epithelial 
monolayers in mouse ileum incubated ex vivo with acetaldehyde, indicating that 
acetaldehyde disrupts tight junctions in mouse intestinal epithelium. The presence of 
occludin and ZO-1 at the tight junctions in mouse ileum treated with fostriecin 
demonstrated that acetaldehyde-induced tight junction disruption in mouse intestinal 
epithelium is also mediated by PP2A activity. Because lack of PP2A causes cell death, 
and overexpression of PP2A also causes severe problems, genetic study of the role of 
PP2A in acetaldehyde-induced disruption of intestinal epithelial junctions in vivo in mice 
would probably be difficult. The inhibitors could offer a way around the problem, but 
dosing would have to be carefully optimized to minimize morbidity. 
 
 
Acetaldehyde Dephosphorylates Occludin on Thr Residues by a PP2A-dependent 
Mechanism 
 
 A significant body of evidence indicates that tight junctions are regulated by 
protein phosphorylation. Occludin is phosphorylated on serine and threonine residues, 
and this phosphorylation is regulated by protein kinases such as c-Src, c-Yes, PKCη, 
PKCζ and CK (Suzuki et al. 2009; Jain et al. 2011) and protein phosphatases such as 
PTP1B, PP1 and PP2A (Seth et al. 2007; Sheth et al. 2007; Sheth et al. 2009).   
 
 Previous studies showed that PP2A binds to the C-terminal domain of occludin 
(Seth et al. 2007; Sheth et al. 2009). Our co-immunoprecipitation studies demonstrated 
that acetaldehyde increased the association of PP2A with occludin, indicating an 
enhanced interaction of PP2A with the tight junction protein complex. PP2A activity 
associated with occludin also increased on approximately the same time scale. Therefore, 
it is likely that acetaldehyde enhances the direct interaction between occludin and PP2A, 
enhancing PP2A's ability to dephosphorylate occludin and perhaps other proteins in the 
tight junction complex. How this interaction is enhanced is currently unknown. 
   
 Our data show that acetaldehyde induces a rapid dephosphorylation of occludin 
and other tight junction proteins on threonine residues. The occludin dephosphorylation 
was effectively blocked by fostriecin, indicating that PP2A played a role in this effect of 
acetaldehyde. The peptide TPDYFL also blocked dephosphorylation in the presence of 
acetaldehyde, confirming the data from the fostriecin studies. PP2A translocation and 
interaction with tight junction proteins is important for dysregulation in the presence of 
acetaldehyde. 
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 The best-known means of PP2A activation and regulation are methylation of the 
carboxy-terminal leucine of the C-subunit, and phosphorylation of Y307 (Ogris, Gibson, 
and Pallas 1997). These interactions enable specific B-regulatory subunits to bind to the 
A-C trimer, determining substrate specificity and subcellular localization. Previous 
studies demonstrated that tyrosine kinase activity is involved in acetaldehyde-induced 
tight junction disruption (Atkinson and Rao 2001).  In the present study, the prevention of  
occludin dephosphorylation on threonine by genistein indicates that tyrosine kinase 
activity does play a role in acetaldehyde-induced PP2A translocation. According to 
previous studies, phosphorylation of PP2A on Y307 negatively regulates its interaction 
with the B-subunit (Ogris, Gibson, and Pallas 1997).  Y307E mutation of PP2A C-
subunit leads to loss of its interaction with the B-subunit and alters its substrate 
specificity. Therefore, we speculate that tyrosine kinase activity and tyrosine 
phosphorylation of PP2A may increase its affinity for occludin via binding of a B-
regulatory subunit, causing dephosphorylation of occludin on threonine residues. Our 
study also shows that acetaldehyde induces dephosphorylation of claudin-5 on threonine 
residues. However, genistein failed to prevent this dephosphorylation, indicating that the 
mechanism of claudin-5 dephosphorylation is distinct from that of occludin 
dephosphorylation, and independent of the tyrosine phosphorylation of PP2A.  
 
 Prevention of acetaldehyde-induced tight junction disruption by TPDYFL 
suggested that the acetaldehyde-induced PP2A translocation may be mediated by tyrosine 
phosphorylation or carboxy-methylation. Methylation of L309 may be required for the 
interaction of PP2A C-subunit with the B-subunit (Bryant, Westphal, and Wadzinski 
1999).  Our studies show that methylated PP2A is present in the untreated Caco-2 cells, 
but acetaldehyde failed to alter the level of methyl-PP2A. This failure indicates that 
methylation is not involved in the mechanism of acetaldehyde-induced PP2A 
translocation, occludin dephosphorylation or tight junction disruption. 
 
 Further studies in this area are needed to determine how acetaldehyde activates 
tyrosine kinase activity. Whether the actions of acetaldehyde are due to adduct formation 
or activation of signaling pathways in the cell is unknown. Measurement of changes in 
mass of occludin, claudins, PP2A, and other tight junction proteins could be used to 
determine whether acetaldehyde causes direct adduct formation with these proteins. 
Electrophoretic separation of proteins in a two-dimensional gel could be used to detect 
changes in protein mass with acetaldehyde treatment. Mass spectrometry of isolated 
proteins could be used to confirm changes found.   
 
 
Acetaldehyde Inhibits Cell Migration by a Mechanism That Does Not Involve PP2A 
 
 Earlier studies have shown that chronic acetaldehyde treatment alters the 
proliferation, adhesion, and differentiation properties of Caco-2 cells (Koivisto and 
Salaspuro 1998). In the presence of low, non-cytotoxic levels of acetaldehyde (less than 1 
mM) for up to 5 weeks, proliferation slowed, but continued to occur at half the pace of 
untreated cells. Adhesion to collagens I and IV was altered, so that cells exposed to 1 mM 
acetaldehyde could not be passaged due to low adhesion rates. Production of sucrase was 
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altered, indicating problems with differentiation (Koivisto and Salaspuro 1998). These 
studies suggested that acetaldehyde alters a variety of characteristics of Caco-2 cells, 
which could be further investigated in our laboratory. With decreased differentiation and 
altered cell-cell contact, we expected acetaldehyde to promote cell migration in a manner 
that would be dependent on PP2A activity for the weakening of tight junctions. Previous 
studies in migrating cells exposed to hydrogen peroxide had indicated accelerated 
migration, so we expected faster migration with acetaldehyde exposure (Basuroy et al. 
2010). 
 
 Two types of cell migration assays were attempted: scratch wounding and 
transmigration. Transmigration did not work (data not shown) because the Caco-2 cells 
did not pass through the 8-micron pores of a permeable filter upon acetaldehyde 
stimulation. Caco-2 cells are used as a monolayer through which immune cells pass in 
models of gastrointestinal immune function (Rescigno et al. 2001). They are also used as 
a model for the invasion of Candida albicans by intra- and intercellular migration (Weide 
and Ernst 1999). Other types of cells can migrate through membranes with a confluent 
monolayer of Caco-2 cells, but the Caco-2 cells themselves do not move. The 
transmigration model was attempted, but Caco-2 cells do not migrate across membranes 
upon acetaldehyde stimulation, even when freshly-seeded, immature cells are used. 
 
 Scratch-wounding assays were attempted using a variety of methods. Scratch-
wounding assays involving a razor blade and scratching away a large cell surface resulted 
in reproducibility issues due to scratching of the underlying plastic. A subsequent trial of 
creating holes by various methods from the literature (small linear scratch, small circular 
scratch, acid, suction) resulted in the selection of the small round hole cut with a 
micropipette tip, a method previously used in several papers (Lotz, Rabinovitz, and 
Mercurio 2000; Farooqui and Fenteany 2005). Due to cohesion of cells, the linear scratch 
model most commonly in use resulted in ripping of the monolayer, with jagged wound 
edges. Acid and suction resulted in large holes. The small, round hole technique was not 
perfect, as compressed cells could block migration, but it was more reproducible than 
other techniques. 
 
 Several experiments using small round holes were conducted. Repeated 
experiments clearly demonstrated that acetaldehyde at very low (3 μM) and high doses 
(100 μM) inhibited cell migration instead of promoting it, with mid-range doses 
comparable to the migration of controls at time points less than twelve hours post-
wounding. Caco-2 cells may be acting as a "normal" epithelium under our current culture 
conditions, in which case our migration assay models wound healing. Acetaldehyde 
would inhibit wound healing in this case. 
 
 Immature monolayers of Caco-2 cells capable of migration seem to detach from 
the underlying substrate rather easily. Acetaldehyde is known to alter the adhesion of 
epithelial cells to underlying substrate in a dose-dependent manner (Koivisto and 
Salaspuro 1998). This complicates the study of the effects of acetaldehyde on cell 
migration. The mature monolayers used for other experiments can be exposed to higher 
concentrations of acetaldehyde without detachment, but they do not migrate. For further 
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studies, consideration of very low-concentration acetaldehyde for prolonged chronic use 
might be appropriate. 
 
 The current results are relevant in the context of wound healing in alcoholics.  
Alcoholics are well known for suffering a variety of surgical risks including delayed 
wound healing and increased risk of infection (Tønnesen 1999). Acetaldehyde has been 
shown in our experiments to cause PP2A-independent delays in wound healing, even in 
an acute-exposure context. With the rise of binge drinking as an important phenomenon 
among young people and a common cause of behavior-related trauma, understanding the 
slowed wound healing caused by excessive alcohol consumption and subsequent 
acetaldehyde exposure is important to optimize approaches to healing in inebriated 
patients. 
 
 
Acetaldehyde Alters Morphology of Cells Grown in Matrigel in a Dose-dependent 
Manner 
 
 Growth of cells in Matrigel or collagen with added growth factors has become a 
popular method to explore how cells grow and differentiate in a three-dimensional matrix 
of extracellular proteins similar to those to which they would attach in vivo (Debnath and 
Brugge 2005). It is used to model growth of cancer cells into tumors (Gudjonsson et al. 
2003) and to explore tubulogenesis in renal tubule cells (Pollack, Runyan, and Mostov 
1998). It has been used previously in Caco-2 cells to explore the role of integrins in 
differentiation (Zhang et al. 2003), with differentiation in this context defined as 
formation of a hollow spheroid of polarized cells, with the apical surfaces toward the 
interior lumen. We expected that acetaldehyde exposure would disrupt this process by 
disrupting the "fence" role of the tight junction in separating apical and basolateral 
populations of membrane proteins. 
 
 Attempts to isolate cells after growth in Matrigel for further biochemical analysis 
were unsuccessful despite use of techniques and buffers found to be productive in 
multiple other cell lines. The end of the isolation procedure yielded no detectable protein. 
All cells were lost. No Western blotting for changes in keratins or vimentin was possible.  
 
 In short, we know that PP2A influences the process of cell differentiation in the 
presence of acetaldehyde in a manner we believe to be dose-dependent. However, the 
difficulties encountered using the techniques required for these studies in the context of 
our cell line, facilities, and the respiratory sensitization effect of acetaldehyde preclude 
any conclusive statements or journal publications based on the data at this time. 
 
 
Summary 
 
 In conclusion, this series of studies adds to the evidence that acetaldehyde 
exposure affects the basic functions of intestinal epithelial cells in vitro and in vivo in a 
dose-dependent manner. The negative effects on tight junction maintenance clearly 
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involve threonine dephosphorylation of occludin and other tight junction proteins via 
PP2A, as indicated by the rescue of tight junction localization of occludin in the presence 
of acetaldehyde by pharmacological inhibition, peptide inhibition, and siRNA. Ex-vivo 
studies of intact ileum confirm these findings. Migration studies show PP2A-independent 
inhibition of migration in the presence of acetaldehyde. Differentiation studies remain 
inconclusive until detailed biochemical analyses can be completed. PP2A affects a 
variety of cell signaling pathways, and acetaldehyde reacts with a variety of cell 
constituents. Their juxtaposition is a challenging study.
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